nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstract converted to O-09.
|
|
|
|
76-77 |
S |
p. S38 |
artikel |
2 |
Abstract converted to O-26.
|
|
|
|
76-77 |
S |
p. S56 |
artikel |
3 |
Abstract converted to P-85
|
|
|
|
76-77 |
S |
p. S11 |
artikel |
4 |
ABSTRACT REVIEWERS
|
|
|
|
76-77 |
S |
p. iii |
artikel |
5 |
ABSTRACT REVIEWERS
|
|
|
|
76-77 |
S |
p. ii |
artikel |
6 |
ABSTRACT REVIEWERS
|
|
|
|
76-77 |
S |
p. |
artikel |
7 |
Abstract withdrawn.
|
|
|
|
76-77 |
S |
p. S53 |
artikel |
8 |
Abstract withdrawn.
|
|
|
|
76-77 |
S |
p. S38 |
artikel |
9 |
Abstract withdrawn.
|
|
|
|
76-77 |
S |
p. S47 |
artikel |
10 |
Abstract withdrawn.
|
|
|
|
76-77 |
S |
p. S61 |
artikel |
11 |
Abstract withdrawn.
|
|
|
|
76-77 |
S |
p. S61 |
artikel |
12 |
Accelerator-produced actinium-225 under the US DOE Tri-Lab collaboration: 2022 update
|
Burgoyne, Andrew |
|
|
76-77 |
S |
p. S42-S43 |
artikel |
13 |
Accelerator production of 71As from metal germanium targets
|
Lo, Yi-Hsuan |
|
|
76-77 |
S |
p. |
artikel |
14 |
Access to 18F-labeled FAP inhibitor variants via [18F]SuFEx reaction
|
Kogler, Jürgen |
|
|
76-77 |
S |
p. S16 |
artikel |
15 |
227Ac Content in Tri-Lab Accelerator-Produced 225Ac: 2023 Update
|
Burgoyne, Andrew |
|
|
76-77 |
S |
p. |
artikel |
16 |
225Ac labeled anti-HER2 2Rs15d sdAb as a potential therapeutic for targeted alpha therapy – an in vitro and in vivo evaluation
|
Rodak, Magdalena |
|
|
76-77 |
S |
p. S33 |
artikel |
17 |
A clickable C-glycosyl scaffold for RGD peptide dimer labelling and application in bimodal [18F]PET/NIRF imaging
|
Jouad, Kamal |
|
|
76-77 |
S |
p. S42 |
artikel |
18 |
A Comparison of Cation Exchange and Extraction Resin Column-based Chromatography Methods for Isolating MURR Produced 161Tb
|
Bokolo, Patrick |
|
|
76-77 |
S |
p. |
artikel |
19 |
A comparison of rhenium isolation and tungsten recovery methods from bulk tungsten targets
|
Charles, Anster |
|
|
76-77 |
S |
p. S104 |
artikel |
20 |
A convenient tritiation strategy for tetrazines
|
Bidesi, Natasha |
|
|
76-77 |
S |
p. S90 |
artikel |
21 |
Actinium-225 labeling of DOTATATE and DOTA-JR11 for the treatment of SSTR2-positive tumors
|
Handula, Maryana |
|
|
76-77 |
S |
p. S191 |
artikel |
22 |
Advances in the automation technologies within LARAMED project
|
Martini, Petra |
|
|
76-77 |
S |
p. S21 |
artikel |
23 |
A facile 18F radiochemistry of making (-)-[18F]TZ8024 for imaging VAChT and initial metabolite analysis in rat plasma and brain
|
Zhao, Haiyang |
|
|
76-77 |
S |
p. S39 |
artikel |
24 |
A facile radiosynthesis of [18F]FBA-Pep42, a cyclic peptide targeting glucose-regulated protein 78 (GRP78)
|
Yang, Hao |
|
|
76-77 |
S |
p. S72 |
artikel |
25 |
A facile synthesis of beta-amyloid PET imaging agent [18F]Florbetaben
|
Akula, Hari |
|
|
76-77 |
S |
p. S85 |
artikel |
26 |
A fluorescent probe as a lead compound for a potential α-syn PET tracer: design and development of a library of RB1 derivatives
|
Di Nanni, Adriana |
|
|
76-77 |
S |
p. S94 |
artikel |
27 |
A fluorescent probe as a lead compound for a selective α-synuclein PET tracer: development of a library of 2-styrylbenzothiazoles and biological evaluation of [18F]PFSB and [18F]MFSB
|
Di Nanni, Adriana |
|
|
76-77 |
S |
p. |
artikel |
28 |
A 68Ga-labeled linear peptide-based PET radiotracers for imaging PD-L1 status in tumors
|
Hu, Kuan |
|
|
76-77 |
S |
p. |
artikel |
29 |
A kit-based approach to aluminium-[18F]fluoride-labelled microbubbles and their in vivo biodistribution following ultrasound-targeted microbubble destruction
|
Teh, Jin Hui |
|
|
76-77 |
S |
p. |
artikel |
30 |
Albumin binders: a potential strategy for enhanced treatment of NETs using SSTR2 antagonists
|
Koustoulidou, Sofia |
|
|
76-77 |
S |
p. S191-S192 |
artikel |
31 |
Al18F-Radiolabeling of PSMA-11 in a media of protic ionic liquids
|
Antuganov, Dmitrii |
|
|
76-77 |
S |
p. S76-S77 |
artikel |
32 |
ALISI – automated light-induced synthesis of 89Zr-labelled antibodies for immuno-PET
|
Klingler, Simon |
|
|
76-77 |
S |
p. S5-S6 |
artikel |
33 |
Alpha particle therapy for the treatment of metastatic tumors of prostate cancer
|
Bidkar, Anil |
|
|
76-77 |
S |
p. |
artikel |
34 |
Alternate radiohalogens for trametinib PET imaging
|
Pratt, Edwin |
|
|
76-77 |
S |
p. S52 |
artikel |
35 |
Alternative protective group strategy for the radiosynthesis of Flortaucipir 18F
|
Xiong, Hui |
|
|
76-77 |
S |
p. S88 |
artikel |
36 |
A 177Lu-labeled anti-HER2 dual variable domain antibody
|
MacPherson, Douglas |
|
|
76-77 |
S |
p. S9 |
artikel |
37 |
A multi-modality platform employing supramolecular chemistry to radiolabel antibodies
|
d’Orchymont, Faustine |
|
|
76-77 |
S |
p. S27-S28 |
artikel |
38 |
A multimodal SPECT: photoacoustic imaging agent for bacterial infection
|
Swann, Rowan |
|
|
76-77 |
S |
p. S62-S63 |
artikel |
39 |
Analysis beyond the image, new prospects in α autoradiography
|
Donnard, Jerome |
|
|
76-77 |
S |
p. |
artikel |
40 |
Analysis of radiochemical stability and in vivo distribution of recoiled 213Bi from [225Ac]Ac-DOTATATE in preclinical model
|
Dijie, Liu |
|
|
76-77 |
S |
p. |
artikel |
41 |
An approach towards reverse generator system for 99mTc separation from LSA 99Mo
|
Cieszykowska, Izabela |
|
|
76-77 |
S |
p. S97 |
artikel |
42 |
An effective process for radiolabelling of bioactive amines from 2,2-difluoro-2-[18F]Fluoro-ethyl 4-methylbenzenesulfonate, a versatile tool for 18F-radiotracer development
|
Maqbool, Mudasir |
|
|
76-77 |
S |
p. S82 |
artikel |
43 |
An Evaluation of the Production of High Specific Activity 155Tb via Alpha-Irradiation of Thick Natural Eu2O3 and Enriched [153Eu] Eu2O3 Targets
|
Charles, Anster |
|
|
76-77 |
S |
p. |
artikel |
44 |
A new in silico approach to revolutionize CNS PET tracer design and enhance translational success
|
Jackson, Isaac |
|
|
76-77 |
S |
p. S24-S25 |
artikel |
45 |
A new paradigm of cancer immunotherapy based on [18F]FDG and anti-PD-L1 mAb combination
|
Wen, Xuejun |
|
|
76-77 |
S |
p. S219-S220 |
artikel |
46 |
A new phenylstannyl precursor for synthesizing [11C]UCB-J
|
Mori, Wakana |
|
|
76-77 |
S |
p. |
artikel |
47 |
A new prospective CB2 receptor tracer based on a 18F labelled naphthyridine core: radiosynthesis and microPET imaging data
|
Pascali, Giancarlo |
|
|
76-77 |
S |
p. S35 |
artikel |
48 |
A new rhenium/technetium-99m complex bearing a quinazoline derivative and 2-picolylamine-N-acetic acid for EGFR imaging
|
Makrypidi, Konstantina |
|
|
76-77 |
S |
p. S15 |
artikel |
49 |
An improved separation scheme for 44Sc purification from proton irradiated calcium
|
Kurakina, Elena |
|
|
76-77 |
S |
p. S92 |
artikel |
50 |
An improved synthesis of [18F]VAT precursor for a one-step radiofluorination
|
Hu, Bao |
|
|
76-77 |
S |
p. S85-S86 |
artikel |
51 |
An interleukin-2 derived small peptide probe for CD25 targeted PET/CT imaging of activated T cells
|
Wang, Shuailiang |
|
|
76-77 |
S |
p. S7 |
artikel |
52 |
An orthogonal labeling strategy to accelerate bioconjugation of [99mTc]Tc-building blocks
|
Braband, Henrik |
|
|
76-77 |
S |
p. S32-S33 |
artikel |
53 |
A novel building block facilitates the synthesis of the 89Zr-Chelator DFO*
|
Feiner, Irene |
|
|
76-77 |
S |
p. |
artikel |
54 |
A novel 18F-labeled reversible PET ligand for imaging monoacylglycerol lipase
|
Rong, Jian |
|
|
76-77 |
S |
p. |
artikel |
55 |
A novel flexible pipetting-based platform for automated microvolume radiochemistry
|
Lu, Yingqing |
|
|
76-77 |
S |
p. S58-S59 |
artikel |
56 |
A novel fluorine-18 labeled P2Y12 receptor PET tracer for imaging of anti-inflammatory microglia
|
van der Wildt, Berend |
|
|
76-77 |
S |
p. S108-S109 |
artikel |
57 |
A novel PET ligand for imaging monoacylglycerol lipase in naïve and mouse models of Alzheimer’s disease
|
Rong, Jian |
|
|
76-77 |
S |
p. S21 |
artikel |
58 |
A Novel Prosthetic group, 4-[18F]Fluorophenylglyoxal for Protein Conjugation
|
Sadasivam, Pragalath |
|
|
76-77 |
S |
p. |
artikel |
59 |
A Novel Purification Method to Improve the Chemical Purity of the 203Pb/212Pb Theranostic Pair
|
McNeil, Brooke |
|
|
76-77 |
S |
p. |
artikel |
60 |
A novel radioiodinated probe for diagnosis of systemic amyloidosis based on thioflavin-T and Congo-red hybrid structure
|
Haratake, Yoshie |
|
|
76-77 |
S |
p. S54-S55 |
artikel |
61 |
A novel radioiodination method for the preparation of radiopharmaceuticals
|
Debnath, Shuvra |
|
|
76-77 |
S |
p. |
artikel |
62 |
A novel radiotracer for imaging autotaxin: [18F]THPDPATX
|
Ebrahimi, Edris |
|
|
76-77 |
S |
p. S186 |
artikel |
63 |
A novel synthesis of [11C]FTIMD
|
Ishii, Hideki |
|
|
76-77 |
S |
p. |
artikel |
64 |
A novel tetrahydrothienopyridine-based PET tracer for P2Y12 receptor imaging in the brain
|
Joseph, Emanuel |
|
|
76-77 |
S |
p. S47 |
artikel |
65 |
Antibody-based PET imaging of alpha-synuclein
|
Syvaenen, Stina |
|
|
76-77 |
S |
p. |
artikel |
66 |
Antibody-based radioligands can distinguish between amyloid-beta subtypes beyond [11C]PiB-positive pathology
|
Syvaenen, Stina |
|
|
76-77 |
S |
p. |
artikel |
67 |
Anti-EphA2 Minibody as a targeting antibody for the molecular imaging of fibrosarcoma tumors.
|
Birikorang, Peggy |
|
|
76-77 |
S |
p. |
artikel |
68 |
Antigen-dependent inducible T cell reporter system for PET imaging of tumor specific antigens
|
Shin, Jaehoon |
|
|
76-77 |
S |
p. |
artikel |
69 |
Antimicrobial peptide form native plant Erythrina crista-galli: a promising agent for diagnostic of infection foci
|
Osorio, Jessica |
|
|
76-77 |
S |
p. S72-S73 |
artikel |
70 |
A pilot study of [18F]AlF-HER2 Affibody in HER2-positive breast cancer patients
|
Guo, Xiaoyi |
|
|
76-77 |
S |
p. S49 |
artikel |
71 |
Application of ionic liquids for ring-opening of non-activated aziridines with [11C]CO2
|
Lindberg, Anton |
|
|
76-77 |
S |
p. S28-S29 |
artikel |
72 |
Application of Machine Learning Driven Computational Approaches for Novel CNS PET Tracer Development
|
Jackson, Isaac |
|
|
76-77 |
S |
p. |
artikel |
73 |
Application of quaternary 1,4-diazabicyclo[2.2.2]octan (DABCO) salts for SN2 “minimalist” radiofluorination
|
Keuthen, Yannick |
|
|
76-77 |
S |
p. S49 |
artikel |
74 |
A Practical Production of Clinical Interesting Radiotracer [11C]UCB-J
|
Akula, Hari |
|
|
76-77 |
S |
p. |
artikel |
75 |
Apramer-based synthesis of radiopharmaceuticals
|
Belugin, Kirill |
|
|
76-77 |
S |
p. S179 |
artikel |
76 |
A preclinical platform for the radiolabelling and in vivo monitoring of nanoparticles against Crohn’s Disease using live dynamic SPECT imaging
|
Karampelas, Theodoros |
|
|
76-77 |
S |
p. S54-S55 |
artikel |
77 |
A Preclinical Platform to Thoroughly Evaluate Novel Nanocomposites in the Full Spectrum of Drug Discovery (in vitro - in vivo - ex vivo) Towards Cancer Treatment
|
Sarpaki, Sophia |
|
|
76-77 |
S |
p. |
artikel |
78 |
A Preliminary Study of the Ortho Effect on Radiofluorinations Using Aryl Sulfonium Salt Precursors
|
Zhang, Wei |
|
|
76-77 |
S |
p. |
artikel |
79 |
A pretargeting approach to PET imaging with antibodies
|
Penawou, Pamela |
|
|
76-77 |
S |
p. S59-S60 |
artikel |
80 |
A pyrene-phthalocyanine conjugate for dual Cherenkov radiation-induced near-infrared luminescence imaging and photodynamic therapy
|
lioret, Vivian |
|
|
76-77 |
S |
p. S105-S106 |
artikel |
81 |
A quest for simplicity: automated cassette-based purification of [61Cu]CuCl2 from solid Ni targets using a single time-list
|
Svedjehed, Johan |
|
|
76-77 |
S |
p. S170 |
artikel |
82 |
A rapid non-radiometric LC-MS/MS procedure for measuring the molar activity of cyclotron-produced [18F]fluoride
|
Ellin, Nicholas |
|
|
76-77 |
S |
p. |
artikel |
83 |
Aryliodonium ylides as efficient precursors for astatine-211 labeling
|
Maingueneau, Clémence |
|
|
76-77 |
S |
p. S174-S175 |
artikel |
84 |
Arylpalladium complexes on solid supports for convenient last-step labelling of bioconjugates by [11C]CO
|
Hermange, Philippe |
|
|
76-77 |
S |
p. S72 |
artikel |
85 |
A side-by-side comparison of a monomer- versus a dimer-based 68Ga- and 177Lu-labeled FAP inhibitor for theranostic tumor stroma targeting
|
Läppchen, Tilman |
|
|
76-77 |
S |
p. |
artikel |
86 |
A simple and fully automatic production of [18F]SMBT-1 using an All-in-One chemistry module
|
Ko, Nare |
|
|
76-77 |
S |
p. |
artikel |
87 |
A simplified radiosynthesis of [18F]FMPEP for imaging CB1 receptors
|
Pees, Anna |
|
|
76-77 |
S |
p. S83 |
artikel |
88 |
A single-pot photo-induced reaction for zirconium-89 radioimmunoPET agents: an efficient approach for translation of radiolabeled antibodies for human use
|
Fong, Cyril |
|
|
76-77 |
S |
p. S119-S120 |
artikel |
89 |
Assessing the binding affinity of a 64Cu-labeled PSMA ligand in a micro physiological system
|
Sihver, Wiebke |
|
|
76-77 |
S |
p. |
artikel |
90 |
Assessment for anti-fatigue effect of traditional oriental medicine via PET/CT
|
Park, Sun Mi |
|
|
76-77 |
S |
p. |
artikel |
91 |
Assessment of [64Cu]Cu-FAP-2286 in immunocompetent mice bearing pancreatic ductal adenocarcinoma (PDAC) tumors
|
Seo, Jai Woong |
|
|
76-77 |
S |
p. |
artikel |
92 |
Assessment of novel mesothelin specific human antibody VH-Fc fusion proteins-based PET agents
|
Cortez, Angel |
|
|
76-77 |
S |
p. |
artikel |
93 |
Assessment of the influence of [18F]florastamin isomer on pharmacokinetic properties for prostate cancer diagnosis: preclinical comparison of biodistribution
|
Lee, Kyongkyu |
|
|
76-77 |
S |
p. |
artikel |
94 |
A stable and robust production process of [18F]fluorodeprenyl-D2 using a cassette-type chemistry module
|
Ko, Nare |
|
|
76-77 |
S |
p. |
artikel |
95 |
Astatine-211 based PSMA-inhibitors for targeted alpha-therapy of prostate cancer
|
Poulie, Christian |
|
|
76-77 |
S |
p. S60 |
artikel |
96 |
A structure-activity relationship study of bimodal BODIPY-labeled PSMA-targeting bioconjugates
|
Stemler, Tobias |
|
|
76-77 |
S |
p. S26-S27 |
artikel |
97 |
A study to obtain a highly reproducible radiochemical yield (RCY) in the PSMA-11 radiolabeling
|
Iudicello, Antonella |
|
|
76-77 |
S |
p. S142-S143 |
artikel |
98 |
At-211-labeled L-tyrosine derivatives via neopentyl scaffold for targeted α-therapy
|
Kaizuka, Yuta |
|
|
76-77 |
S |
p. S12-S13 |
artikel |
99 |
A trifluoroborate (BF3) radioprosthetic group bearing FAP-targeting ligand for facile labeling with 18F via the 18F-19F isotope exchange reaction: synthesis, radiolabeling and in vivo evaluation
|
Bendre, Shreya |
|
|
76-77 |
S |
p. S179-S180 |
artikel |
100 |
Auger electrons in radionuclide therapy: Szilárd-Chalmers effect/hot atom chemistry during the targeted delivery of the isotopes
|
Szucs, Zoltán |
|
|
76-77 |
S |
p. |
artikel |
101 |
Au@Pt core-shell nanoparticle bioconjugates for Auger electron radiotherapy – preliminary studies
|
Wawrowicz, Kamil |
|
|
76-77 |
S |
p. S82-S83 |
artikel |
102 |
Author Index
|
|
|
|
76-77 |
S |
p. S223-S235 |
artikel |
103 |
AUTHOR INDEX
|
|
|
|
76-77 |
S |
p. S76-S81 |
artikel |
104 |
Author Index
|
|
|
|
76-77 |
S |
p. S109-S114 |
artikel |
105 |
Author Index
|
|
|
|
76-77 |
S |
p. |
artikel |
106 |
Automated cassette based synthesis of novel CB1 receptor tracer [18F]FPATPP produced via Ru-mediated 18F-fluorination
|
Rajala, Noora |
|
|
76-77 |
S |
p. |
artikel |
107 |
Automated Clinical Radiosynthesis of [18F]-F-AraG using the Elixys FLEX/CHEM and PURE/FORM Synthesis System
|
Deyerle, Phillip |
|
|
76-77 |
S |
p. |
artikel |
108 |
Automated 18F-Al-radiolabelling optimization of PSMA-11 for PET imaging using a design of experiments approach
|
Wagner, Laurène |
|
|
76-77 |
S |
p. S138-S139 |
artikel |
109 |
Automated multidoses production of [68Ga]PentixaFor in general purpose commercial module and its preclinical evaluation in lymphoma model
|
Sahu, Sudeep |
|
|
76-77 |
S |
p. S211 |
artikel |
110 |
Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter
|
Tu, Zhude |
|
|
76-77 |
S |
p. |
artikel |
111 |
Automated production of [18F]AldoView: first translation of a sulfonium salt precursor to GMP
|
Sirindil, Fatih |
|
|
76-77 |
S |
p. S137 |
artikel |
112 |
Automated production of sodium [11C]butyrate
|
Pakula, Ryan |
|
|
76-77 |
S |
p. S70-S71 |
artikel |
113 |
Automated purification of 18F-compounds by semi-preparative supercritical fluid chromatography (SFC)
|
Maindron, Nicolas |
|
|
76-77 |
S |
p. S22-S23 |
artikel |
114 |
Automated purification of radiometals produced by solid targets
|
Gongora-Servin, Benito |
|
|
76-77 |
S |
p. |
artikel |
115 |
Automated radiolabeling of [68Ga]Ga-DOTATOC using the iMiDEV™ automated microfluidic radiosynthesizer
|
Chandrashekara, Hemantha Kumara |
|
|
76-77 |
S |
p. S122-S123 |
artikel |
116 |
Automated radiosyntheses of [18F]FMPEP-d 2 and [18F]MAGL-2102 for imaging the endocannabinoid system
|
Pees, Anna |
|
|
76-77 |
S |
p. |
artikel |
117 |
Automated radiosynthesis of [18F]AlF-FAPI-42
|
Gröner, Benedikt |
|
|
76-77 |
S |
p. S61-S62 |
artikel |
118 |
Automated radiosynthesis of [18F]AV-45 using Elixys FLEX/CHEM and PURE/FORM synthesis system
|
Miller, William |
|
|
76-77 |
S |
p. S132 |
artikel |
119 |
Automated radiosynthesis of [18F]DOPA and [18F]FMT via copper-mediated nucleophilic F-18 Fluorination of arylstannanes on a new synthesizer
|
Nagachinta, Surasa |
|
|
76-77 |
S |
p. S133-S134 |
artikel |
120 |
Automated radiosynthesis of 6-[18F]F-L-DOPA from a boronic precursor on NEPTIS® module
|
Maindron, Nicolas |
|
|
76-77 |
S |
p. S129 |
artikel |
121 |
Automated radiosynthesis of [18F]FMeNER-D2 using the simplified one-pot 18F-fluoromethylation.
|
Zhang, Ming-Rong |
|
|
76-77 |
S |
p. |
artikel |
122 |
Automated radiosynthesis of meta-[18F]Fluorobenzylguanidine from a diaryliodonium salt precursor on NEPTIS® module
|
Maindron, Nicolas |
|
|
76-77 |
S |
p. S131 |
artikel |
123 |
AUTOmated radiosynthesis of para-[131I]Iodo-L-phenylalanine on NEPTIS® module
|
Maindron, Nicolas |
|
|
76-77 |
S |
p. S130-S131 |
artikel |
124 |
Automated radiosynthesis of the 18F-labeled BF2-chelated tetraaryl-azadipyrromethenes photosensitizer using isotopic exchange
|
Kawamura, Kazunori |
|
|
76-77 |
S |
p. S81-S82 |
artikel |
125 |
Automated synthesis and quality control of [18F]FFNP with GMP compliance
|
Kim, Dong Hyun |
|
|
76-77 |
S |
p. S127-S128 |
artikel |
126 |
Automated synthesis of D-[3-11C]Alanine on the Sofie Biosciences Elixys Flex/Chem
|
Simpson, Spenser |
|
|
76-77 |
S |
p. S136-S137 |
artikel |
127 |
Automated synthesis of 16-[131I]iodohexadecanoic acid: a lymphatic leakage tracer
|
Plhak, Elisabeth |
|
|
76-77 |
S |
p. S59-S60 |
artikel |
128 |
Automation of 4-[18F]fluorogabapentin radiosynthesis
|
Zhou, Yu-Peng |
|
|
76-77 |
S |
p. S66 |
artikel |
129 |
Automation of two-step one-vessel ditosylate synthon fluorination using Trasis AllinOne
|
Lee, Hsiaoju |
|
|
76-77 |
S |
p. |
artikel |
130 |
Automation of two-step synthesis of [18F]FP-TMP using Trasis AllinOne
|
Lee, Hsiaoju |
|
|
76-77 |
S |
p. S127 |
artikel |
131 |
A versatile cassette-based adaptor for solid targets dissolution on commercial synthesis modules
|
Sciacca, Gabriele |
|
|
76-77 |
S |
p. S46-S47 |
artikel |
132 |
3-Aza-6-[18F]fluoro-isatoic anhydrides ([18F]AFIAs) - novel prosthetic groups for indirect radiolabeling
|
Willmann, Michael |
|
|
76-77 |
S |
p. S28 |
artikel |
133 |
131Ba as a promising SPECT-diagnostic match for 223/224Radium
|
Reissig, Falco |
|
|
76-77 |
S |
p. S95 |
artikel |
134 |
Behind the scenes of Ga-68-Trivehexin development: unique structure-activity relationships
|
Quigley, Neil |
|
|
76-77 |
S |
p. S208-S209 |
artikel |
135 |
8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for PET imaging of the A1 adenosine receptor
|
Holschbach, Marcus |
|
|
76-77 |
S |
p. S26-S27 |
artikel |
136 |
Bifunctional [2.2.2]-cryptands: Selective and efficient chelators for the 203Pb/212Pb theranostic pair
|
McDonagh, Anthony |
|
|
76-77 |
S |
p. |
artikel |
137 |
Binding of [64Cu]DOTATATE beyond the BBB
|
Andersen, Ida |
|
|
76-77 |
S |
p. S172-S173 |
artikel |
138 |
Bioconjugates labeled with Auger electron emitter: 135La, as potential therapeutic radiopharmaceutical
|
Walczak, Rafał |
|
|
76-77 |
S |
p. S159 |
artikel |
139 |
Bioconjugates of 103Pd/103mRh in-vivo generator for targeted Auger electron therapy
|
Gieraltowska, Joanna |
|
|
76-77 |
S |
p. S188-S189 |
artikel |
140 |
Biodistribution of a 67Ga-labeled anti-TNF VHH single-domain antibody containing a bacterial albumin-binding domain (Zag)
|
Morais, Maurício |
|
2014 |
76-77 |
S |
p. e44-e48 nvt p. |
artikel |
141 |
Biodistribution of [89Zr]DFO-Maleimide-VLP-1 in Wistar Rats by Positron Emission Tomography (PET)
|
Riffel, Kerry |
|
|
76-77 |
S |
p. |
artikel |
142 |
Biological evaluation of [18F]FDG-Tz as a tracer candidate for pretargeted PET imaging
|
Auchynnikava, Tatsiana |
|
|
76-77 |
S |
p. S71-S72 |
artikel |
143 |
Biological evaluation of 111In-clickable complexes for cancer theranostics
|
D’Onofrio, Alice |
|
|
76-77 |
S |
p. S188 |
artikel |
144 |
Bioorthogonal chemistry approach for theranostics of GRPR-expressing cancers
|
Gano, Lurdes |
|
|
76-77 |
S |
p. S30 |
artikel |
145 |
2,6-Bis-(N-hydroxylamino)-1,3,5-triazines as ligands for 45Ti-chelation
|
Hoffmann, Chris |
|
|
76-77 |
S |
p. |
artikel |
146 |
Bispecific antibody-based radiopharmaceutical towards phosphorylated TDP-43
|
Pakula, Ryan |
|
|
76-77 |
S |
p. S103 |
artikel |
147 |
Bispidine - One chelator to bind lutetium-177 and actinium-225
|
Brühlmann, Santiago |
|
|
76-77 |
S |
p. |
artikel |
148 |
Bispidin-9-ol derivatives for copper-64:67 radiolabeling and facile biofunctionalization strategies
|
Wünsche, Adrian |
|
|
76-77 |
S |
p. S74-S75 |
artikel |
149 |
Blood–brain barrier penetrating peptide-based radioligands targeting the EGFR:EGFRvIII receptors
|
Schuderer, Franziska |
|
|
76-77 |
S |
p. S71-S72 |
artikel |
150 |
Blood-brain barrier permeable antibodies for brain imaging
|
van den Broek, Sara Lopes |
|
|
76-77 |
S |
p. |
artikel |
151 |
Borylation and 18F-Fluorination of arenes mediated by Lewis-acid organocatalysts
|
Garcia, Raul Perez |
|
|
76-77 |
S |
p. S84 |
artikel |
152 |
Brain energetics by biomedical modalities
|
Tiwari, Anjani |
|
|
76-77 |
S |
p. S108 |
artikel |
153 |
Bringing personalized medicine to the next level: RANKL immuno-PET imaging using [64Cu]Cu-NOTA-anti-RANKL-Fab fragments
|
Dewulf, Jonatan |
|
|
76-77 |
S |
p. S184-S185 |
artikel |
154 |
Bucherer-Bergs multicomponent reaction with [11C]CO2, a facile and divergent synthesis of 11C-labelled hydantoins
|
van der Aa, Frank |
|
|
76-77 |
S |
p. S75 |
artikel |
155 |
Cancer theranostics using radiolabelled PARP inhibitors
|
Ferrat, Mélodie |
|
|
76-77 |
S |
p. |
artikel |
156 |
Can the Radiochemical Purity of 225Ac-Labeled Compounds be Accurately Assessed by Radio-TLC Alone?
|
Wacker, Anja |
|
|
76-77 |
S |
p. |
artikel |
157 |
Capsular reformulation of the PET radiopharmaceutical [18F]FTHA for oral administration
|
Moerlein, Stephen |
|
|
76-77 |
S |
p. S144 |
artikel |
158 |
Carbamoyl fluoride as a potential new tag for 18F-labeling
|
Bonnefoy, Clémence |
|
|
76-77 |
S |
p. S77-S78 |
artikel |
159 |
Carbasugars synthesis and derivatization: a new labelling strategy with 99mTc for infection diagnostic agents
|
Gretter, Mariella Terán |
|
|
76-77 |
S |
p. S40-S41 |
artikel |
160 |
Carbon-11 carboxylation of trialkoxysilane and trimethylsilane derivatives using [11C]CO2
|
Bongarzone, Salvatore |
|
|
76-77 |
S |
p. S68 |
artikel |
161 |
Carbon-11 labelled isocyanides: new versatile building blocks to access novel PET tracers
|
Bonnemaire, Coralie |
|
|
76-77 |
S |
p. S27-S28 |
artikel |
162 |
Carbon-11 Labelling of Benzenesulfonamide Analogues as Novel Radiotracers to Visualize the Pore-forming Activity of Perforin
|
Zhang, Bo |
|
|
76-77 |
S |
p. |
artikel |
163 |
Cationic pH-responsive albumin binding ligands (ABLs) for enhanced cancer-specific theranostics
|
Lee, Jeong-Seob |
|
|
76-77 |
S |
p. |
artikel |
164 |
11C-Carbonylation using TracerLab FX Synthesis modules
|
Shao, Xia |
|
|
76-77 |
S |
p. S136 |
artikel |
165 |
[11C]Carboxylated tetrazines for facile labeling of trans-cyclooctene-functionalized macromolecules
|
Vázquez, Rocío García |
|
|
76-77 |
S |
p. S71-S72 |
artikel |
166 |
11C-Carboxylation via organic photoredox-catalyzed isotopic exchange
|
Munch, Maxime |
|
|
76-77 |
S |
p. S29 |
artikel |
167 |
CD46 targeted, Actinium-225 labelled antibody for treatment of prostate cancer xenografts
|
Bidkar, Anil |
|
|
76-77 |
S |
p. S31 |
artikel |
168 |
CD133-Targeted Radioimmunotherapy of Small Cell Lung Cancer
|
Sebastiano, Joni |
|
|
76-77 |
S |
p. |
artikel |
169 |
Cell membrane localization of terbium-161 using peptide receptor antagonists: can we profit from Auger electron emission with non-internalizing targeting agents?
|
Müller, Cristina |
|
|
76-77 |
S |
p. S26 |
artikel |
170 |
Centralized GMP production of [90Y]Y-PentixaTher for clinical trials
|
Berroteran-Infante, Neydher |
|
|
76-77 |
S |
p. S121 |
artikel |
171 |
Cerenkov Luminescence Signal Enhancement using Hyperbolic Metamaterials as a Multi-modal Imaging Probe
|
Boykoff, Natalie |
|
|
76-77 |
S |
p. |
artikel |
172 |
cGMP synthesis of 4-[18F]fluoro-1-naphthol, a novel PET tracer for imaging activation of innate immunity
|
Pisaneschi, Federica |
|
|
76-77 |
S |
p. |
artikel |
173 |
11C-guanylated histamine for PET cardiac imaging
|
Mhanna, Karim |
|
|
76-77 |
S |
p. |
artikel |
174 |
C-H activation: optimisation of palladium mediated 11C methylation
|
Ariztia, Julen |
|
|
76-77 |
S |
p. S70 |
artikel |
175 |
Characterization of a PET radioligand suitable for imaging and quantification of sigma-2 receptor in the primate brain
|
Zheng, Ming-Qiang |
|
|
76-77 |
S |
p. S5 |
artikel |
176 |
Characterization of new FSHβ-derived peptide probes for the validation of FSHR as a new prognostic and predictive biomarker in primary and metastatic cancers
|
Carpanese, Debora |
|
|
76-77 |
S |
p. S89 |
artikel |
177 |
Chelation of Manganese - 52 for development of long-lived PET radiopharmaceuticals
|
Omweri, James |
|
|
76-77 |
S |
p. |
artikel |
178 |
Chelator-based non-peptidic radiotracers for PET imaging of PD-L1 with copper-64
|
Krutzek, Fabian |
|
|
76-77 |
S |
p. S38 |
artikel |
179 |
Chemically Identical Pair of Theranostic Small-Molecule Drug Conjugates for Prostate Cancer Imaging and Chemotherapy
|
Hao, Guiyang |
|
|
76-77 |
S |
p. |
artikel |
180 |
Chemoenzymatic Synthesis of Fluorine-18-Labelled Disaccharides Used for PET Imaging of Bacteria Infection
|
Sorlin, Alexandre |
|
|
76-77 |
S |
p. |
artikel |
181 |
Cholesterol-depleting drugs for HER2-targeted radioimmunotherapy of patient-derived esophagogastric (EG) cancer
|
Rao, Yi |
|
|
76-77 |
S |
p. S210-S211 |
artikel |
182 |
Choosing the right molar activity of an 122I-labeled irreversible inhibitor of transglutaminase 2 for quantitative expression profiling in tissues
|
Donat, Cornelius |
|
|
76-77 |
S |
p. S220 |
artikel |
183 |
Chromophore-conjugated NCS-activated NODAGA is a versatile tool for quantitative prediction of protein-chelator conjugation for 64Cu-immunoPET
|
Seyfried, Dominik |
|
|
76-77 |
S |
p. S10-S11 |
artikel |
184 |
[11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics
|
Cools, Romy |
|
|
76-77 |
S |
p. |
artikel |
185 |
11C-labelled oxadiazoles via 11C-labelled acyl amidines through a one-pot, two-step reaction
|
Rydfjord, Jonas |
|
|
76-77 |
S |
p. S74 |
artikel |
186 |
Click-cleavable 111In/177Lu-labeled DOTA-TCO-trastuzumab for imaging and therapy of breast cancer
|
de Roode, Kim |
|
|
76-77 |
S |
p. S16 |
artikel |
187 |
Clinical grade [15O]O2 Production for Human Inhalation PET/MRI study
|
Park, Jun Hyung |
|
|
76-77 |
S |
p. |
artikel |
188 |
Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors
|
Orlova, Anna |
|
|
76-77 |
S |
p. S58 |
artikel |
189 |
11C-MePro PET/CT Imaging in Normal Volunteers: Initial Evaluation of PET-based Human Biodistribution
|
Yamazaki, Kana |
|
|
76-77 |
S |
p. |
artikel |
190 |
[55Co]Co-DOTA-SP4: Towards NK1R-targeted Theranostics of Glioblastoma
|
Laursen, Vigga |
|
|
76-77 |
S |
p. |
artikel |
191 |
Combined PD-L1–targeted radionuclide therapy with immunotherapy in two models of colorectal cancer
|
Wen, Xuejun |
|
|
76-77 |
S |
p. S33 |
artikel |
192 |
Combining Positron Emission Tomography and Hyperpolarized Magnetic Resonance to Interrogate Prostate Cancer Metabolism
|
Enriquez, Jose |
|
|
76-77 |
S |
p. |
artikel |
193 |
Come up smelling of roses – Using a real-time radioligand assay to elucidate PD-L1 binding of different ligand classes
|
Donat, Cornelius |
|
|
76-77 |
S |
p. |
artikel |
194 |
Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy
|
Gouard, S. |
|
2014 |
76-77 |
S |
p. e30-e35 nvt p. |
artikel |
195 |
Comparative evaluation by SPECT and PET imaging of two immuno-pre-targeting systems in an in vivo model of triple negative breast tumours with anti-EGFR antibodies
|
Briat, Arnaud |
|
|
76-77 |
S |
p. S204-S205 |
artikel |
196 |
Comparative evaluation of 177Lu-DOTATATE and 90Y-DOTATATE in SSTR II overexpressing Xenograft models for treatment of variable volume neuroendocrine tumours
|
Tawate, Megha |
|
|
76-77 |
S |
p. S213-S214 |
artikel |
197 |
Comparative in vivo biodistribution and dosimetry in non-human primate of the fibroblast activation protein radiotracers [68Ga]Ga-FAPI-04, [68Ga]Ga-FAPI-46 and [18F]FAPI-74
|
Tran, Thuy |
|
|
76-77 |
S |
p. S216-S217 |
artikel |
198 |
Comparative in vivo PET/CT, biodistribution, and excretion study of Cu-64 labeled Polypropylene (PP) nanoplastics via various administration routes in mice
|
Kwon, Mihye |
|
|
76-77 |
S |
p. |
artikel |
199 |
Comparing the day-to-day production of [68Ga]Ga-PSMA-11 using Locametz and Illuccix Kits
|
Wang, Ivan |
|
|
76-77 |
S |
p. |
artikel |
200 |
Comparison of a radiolabeled somatostatin agonist with an antagonist using the SSTR2 expressing cell line BON-1S in 2D and 3D models
|
Sihver, Wiebke |
|
|
76-77 |
S |
p. S212-S213 |
artikel |
201 |
Comparison of biodistribution according to administration route for the development of liposome therapeutics
|
Yoo, Ran Ji |
|
|
76-77 |
S |
p. S165 |
artikel |
202 |
Comparison of [11C] and [18F] labelled D-amino acid tracers for imaging of bacterial infection
|
Lopez-Alvarez, Marina |
|
|
76-77 |
S |
p. |
artikel |
203 |
Comparison of cyclotron produced manganese-52 from natural chromium and vanadium targets
|
Nielsen, Karin Michaelsen |
|
|
76-77 |
S |
p. S171-S172 |
artikel |
204 |
Comparison of DOTA, NODAGA and 15-5 macrocycles as chelators for 64Cu-labelling of immunoconjugates
|
Maisonial-Besset, Aurélie |
|
|
76-77 |
S |
p. S153-S154 |
artikel |
205 |
Comparison of Evans Blue vs 4-(p-iodophenyl)butyric acid albumin binding moieties for lutetium-177-labeled LLP2A derivatives as theranostic agents for metastatic melanoma
|
Pun, Michael |
|
|
76-77 |
S |
p. S61 |
artikel |
206 |
Comparison of [18F]FEOBV, [3H]VAT, [3H]MK-6884 and [3H]JNJ-64511070 for imaging Alzheimer’s disease
|
d’Orchymont, Faustine |
|
|
76-77 |
S |
p. |
artikel |
207 |
Comparison of [18F]PSMA-1007 with Novel 18F-Labeled PSMA Inhibitor
|
Donat, Cornelius |
|
|
76-77 |
S |
p. |
artikel |
208 |
Comparison of [68Ga]Ga precursors for blood cell radiolabeling
|
Bouvry, Christelle |
|
|
76-77 |
S |
p. S57 |
artikel |
209 |
Comparison of the Biodistribution of [18F]FNP-59 and its Esters
|
Brooks, Allen |
|
|
76-77 |
S |
p. |
artikel |
210 |
Comparison of the syntheses of 18F-labelled norepinerphrine transporter tracer [18F]NS12137 using in-house built device and Trasis AllinOne
|
Rajala, Noora |
|
|
76-77 |
S |
p. |
artikel |
211 |
Comparison of two cyclen-based phosphonates for development of bone-seeking lutetium-177 radiopharmaceuticals
|
Mitrofanov, Iurii |
|
|
76-77 |
S |
p. S70-S71 |
artikel |
212 |
Comparison of Voxelized Monte Carlo and OLINDA Dosimetry Methods Towards 67Cu-LLP2A Therapy from 64Cu-LLP2A PET/CT Imaging Data
|
Bellavia, Michael |
|
|
76-77 |
S |
p. |
artikel |
213 |
Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer
|
Ho, Van |
|
|
76-77 |
S |
p. |
artikel |
214 |
Complexation of [186Re][Re(CO)3]+ and [99mTc][Tc(CO)3]+ cores with TACN-based chelators
|
Hoerres, Rebecca |
|
|
76-77 |
S |
p. |
artikel |
215 |
Computational design, synthesis and radiolabelling of a novel octacoordinate chelator for 89Zr
|
Klingler, Simon |
|
|
76-77 |
S |
p. S45-S46 |
artikel |
216 |
Conception of Nanoparticles as Diagnostic Agents
|
Mignet, Nathalie |
|
|
76-77 |
S |
p. S2-S3 |
artikel |
217 |
CONTENTS
|
|
|
|
76-77 |
S |
p. iii |
artikel |
218 |
Contents
|
|
|
2014 |
76-77 |
S |
p. IBC- 1 p. |
artikel |
219 |
CONTENTS
|
|
|
|
76-77 |
S |
p. |
artikel |
220 |
Convenient preparation of 18F-labeled human insulin by Pd-catalyzed S-arylation
|
Humpert, Swen |
|
|
76-77 |
S |
p. S116-S117 |
artikel |
221 |
Copper-61 as an alternative to Gallium-68 for radiopharmaceutical production: feasibility study and scale-up for clinical doses
|
Fonseca, Alexandra |
|
|
76-77 |
S |
p. S21-S22 |
artikel |
222 |
Copper catalyzed radiobromination of boronic pinacol esters: utility in PARP inhibitor synthesis
|
Mixdorf, Jason |
|
|
76-77 |
S |
p. S175 |
artikel |
223 |
Copper-free click labeling with the [99mTc]Tc-tricarbonyl-core using DACN derivatives
|
Mamat, Constantin |
|
|
76-77 |
S |
p. S37 |
artikel |
224 |
Copper-61 from liquid targets: optimized purification for GMP labelling
|
Fonseca, Alexandra |
|
|
76-77 |
S |
p. S98-S99 |
artikel |
225 |
Copper-mediated 18F-fluorination of boroxines: a systematic optimization study
|
Bolik, Kim-Viktoria |
|
|
76-77 |
S |
p. S35-S36 |
artikel |
226 |
Copper mediated radiocyanation of aryl halides
|
Sharninghausen, Liam |
|
|
76-77 |
S |
p. S29-S30 |
artikel |
227 |
Corrole radiolabelling with 68Ga, 64Cu and 67Cu - a novel approach for theranostic applications in cancer
|
Ekaney, Thomas Kolle |
|
|
76-77 |
S |
p. |
artikel |
228 |
Covalent Modification of Black Phosphorus Nanosheets with 89-Zirconium
|
Shen, Jieting |
|
|
76-77 |
S |
p. |
artikel |
229 |
11C-Radiolabeling of α-amino acids via aldehyde-promoted isotopic exchange reaction
|
Munch, Maxime |
|
|
76-77 |
S |
p. S29 |
artikel |
230 |
C(sp3)-H functionalization for access to [11C]amino acids
|
Edgar, Fraser |
|
|
76-77 |
S |
p. S68-S69 |
artikel |
231 |
64Cu-DOTHA2-PSMA, a novel theranostic agent for prostate cancer and its preclinical animal evaluation
|
Milot, Marie-Christine |
|
|
76-77 |
S |
p. S105 |
artikel |
232 |
Cu-64 heterodimers targeting GRPR: PSMA expressing cells: in vitro and in vivo investigations
|
Chambers, Claudia |
|
|
76-77 |
S |
p. S8 |
artikel |
233 |
64Cu-labeled fucoidan nanoparticles for non-invasive PET/CT tumor imaging
|
Kim, Kyungwon |
|
|
76-77 |
S |
p. |
artikel |
234 |
64Cu-labeled panitumumab for PET imaging of EGFR+ non-small cell lung cancer: Subcutaneous and metastatic mouse models
|
Wuest, Frank |
|
|
76-77 |
S |
p. |
artikel |
235 |
64Cu-labeled TCP-1 probe for PET imaging of colorectal cancer
|
Li, Feng |
|
|
76-77 |
S |
p. |
artikel |
236 |
64Cu-Lazarus: bringing our [64Cu]CuCl2 manufacturing system back to life
|
Stimson, Damion |
|
|
76-77 |
S |
p. |
artikel |
237 |
Cu-mediated 18F-radiofluorination of various stannylated FDOPA precursors – what is feasible?
|
Kniess, Torsten |
|
|
76-77 |
S |
p. |
artikel |
238 |
64Cu production via the 68Zn(p,nα)64Cu nuclear reaction: Targetry, radiochemistry and PET imaging for utility assessment
|
Nelson, Bryce |
|
|
76-77 |
S |
p. |
artikel |
239 |
Curcumin-based 68Ga-radiotraces: radiolabeling strategies and bifunctional chelator approach
|
Mari, Matteo |
|
|
76-77 |
S |
p. S69 |
artikel |
240 |
Current developments in the production of actinium-225 from thorium-229
|
Benny, Paul |
|
|
76-77 |
S |
p. S42 |
artikel |
241 |
[11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor
|
Högnäsbacka, Antonia |
|
|
76-77 |
S |
p. |
artikel |
242 |
Cyclic [68Ga] and [18F]AlF-labeled peptides for specific detection of human angiotensin-converting enzyme 2
|
Wilson, David |
|
|
76-77 |
S |
p. S64-S65 |
artikel |
243 |
CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes
|
Jaworski, Carolin |
|
|
76-77 |
S |
p. |
artikel |
244 |
Cyclotron-based Production of Lanthanum-133 with High Radionuclidic Purity for Theranostic Purposes
|
Brühlmann, Santiago |
|
|
76-77 |
S |
p. |
artikel |
245 |
Cyclotron Production of Copper-67: Exploring the limits
|
Brühlmann, Santiago |
|
|
76-77 |
S |
p. |
artikel |
246 |
Cyclotron production of gallium-68 from liquid target: routine production of 68Ga-labelled radiotracers
|
Uhlending, Antje |
|
|
76-77 |
S |
p. S151 |
artikel |
247 |
Cyclotron-production of manganese-52 for multi-modal imaging applications
|
Boschi, Alessandra |
|
|
76-77 |
S |
p. S46 |
artikel |
248 |
Cyclotron-production of Mn-52: an update on the METRICS project
|
Martini, Petra |
|
|
76-77 |
S |
p. S169-S170 |
artikel |
249 |
Cyclotron production of the 64Cu theranostic radiometal using a novel 68Zn sealed solid target
|
Nelson, Bryce |
|
|
76-77 |
S |
p. S171 |
artikel |
250 |
Cyclotron production of the theranostic pair 133/135La for nuclear medicine
|
Nelson, Bryce |
|
|
76-77 |
S |
p. S2-S3 |
artikel |
251 |
Cytotoxicity of the bimodal [224Ra]RaCl2 and [212Pb]Pb-TCMC-TP-3 solution in a multicellular tumor spheroid model of osteosarcoma
|
Tornes, Anna Julie |
|
|
76-77 |
S |
p. S15-S16 |
artikel |
252 |
Delayed 64Cu-DOTA-Rituximab PET image generation for dosimetry using paired image-to-image translation
|
Kim, Kangsan |
|
|
76-77 |
S |
p. |
artikel |
253 |
Demonstrating peptide based nanoconstructs as emerging theranostic biomolecules
|
Khan, Irfan |
|
|
76-77 |
S |
p. S87-S88 |
artikel |
254 |
Demonstration of intracellular pH-weighting PET imaging using a new-type PET probe responsible for monoacylglycerol lipase activity in the brain
|
Yamasaki, Tomoteru |
|
|
76-77 |
S |
p. S112-S113 |
artikel |
255 |
De novo design of alpha-synuclein small molecule PET tracers
|
Korat, Spela |
|
|
76-77 |
S |
p. S97 |
artikel |
256 |
De novo design of lead structures for P2Y12 receptor tracer development using in silico methods
|
Stéen, E. Johanna |
|
|
76-77 |
S |
p. S105-S106 |
artikel |
257 |
Density functional theory experiments offer insight into properties of the Sc-HOPO complex
|
Phipps, Michael |
|
|
76-77 |
S |
p. S71 |
artikel |
258 |
Design and evaluation of new 99mTc/188Re-labeled TSPO-binding ligands for cancer theragnostic
|
Lee, Kyeongyang |
|
|
76-77 |
S |
p. |
artikel |
259 |
Design and synthesis of a new bifunctional chelating agent for 18F-Al/177Lu radiolabelling: theranostic approach
|
Wagner, Laurène |
|
|
76-77 |
S |
p. S12-S13 |
artikel |
260 |
Design and synthesis of fluorinated pyrazolidine-3,5-dione derivatives as potential P2Y12 receptor PET tracers
|
Stéen, E. Johanna |
|
|
76-77 |
S |
p. |
artikel |
261 |
Design and synthesis of monomeric ligands based on published EGFR (epidermal growth factor receptor)-specific peptides for the diagnostic application in malignant transformations
|
Judmann, Benedikt |
|
|
76-77 |
S |
p. |
artikel |
262 |
Design and synthesis of novel heptadentate chelates for 89Zr-radiolabelling of antibodies
|
Guillou, Amaury |
|
|
76-77 |
S |
p. S7 |
artikel |
263 |
Designing and validating the nested neutron spectrometer using for accelerator-based neutron source: Monte Carlo code and artificial intelligence algorithm
|
Tuan, Hoang |
|
|
76-77 |
S |
p. S73 |
artikel |
264 |
Design space approach to optimise the [68Ga]Ga-Pentixafor radiolabelling process
|
Kaufmann, Jens |
|
|
76-77 |
S |
p. S60 |
artikel |
265 |
Design, synthesis and biological evaluation of a small-molecule PET imaging agent for imaging PD-L1 expression
|
Xu, Liang |
|
|
76-77 |
S |
p. |
artikel |
266 |
Design, synthesis, and biological evaluation of orthosteric ligands for the muscarinic acetylcholine receptors
|
Millard, Marlon |
|
|
76-77 |
S |
p. |
artikel |
267 |
Design, Synthesis, and Evaluation of an 18F-Labeling Dendrimer Radiotracer for Positron Emission Tomography (PET) Imaging of Heparanase
|
Pu, Yinglan |
|
|
76-77 |
S |
p. |
artikel |
268 |
Detecting EGFR expression in bladder cancer using [89Zr]Zr-DFO-Panitumumab immunoPET imaging
|
Hoang, Tran |
|
|
76-77 |
S |
p. S194 |
artikel |
269 |
Determination of Association Constants of Macropa-based Chelators for the Stable Complexation of Barium-131 and Lanthanum-133
|
Blei, Magdalena |
|
|
76-77 |
S |
p. |
artikel |
270 |
Determination of 2-chloro-2-deoxy-D-glucose, 2-fluoro-2-deoxy-D-glucose, and glucose in [18F]Fluorodeoxyglucose by capillary electrophoresis
|
Antuganova, Yulia |
|
|
76-77 |
S |
p. S80 |
artikel |
271 |
Developing a Novel Microfluidics-based 86Y Purification Strategy for Rapid and Efficient Radiopharmaceutical Production
|
Ta, Robert |
|
|
76-77 |
S |
p. |
artikel |
272 |
Development and application of a fully automated multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis
|
Cui, Fang-Bo |
|
|
76-77 |
S |
p. |
artikel |
273 |
Development and biological evaluation of 18F-labeled adenosine-A1-receptor partial agonists
|
Evcüman, Sibel |
|
|
76-77 |
S |
p. S9 |
artikel |
274 |
Development and evaluation of fully automated F-18 cromolyn diethyl ester labeling via multi step reaction as potential therapeutics for Alzheimer’s Disease for brain PET imaging
|
Moon, Sung-Hyun |
|
|
76-77 |
S |
p. |
artikel |
275 |
Development and evaluation of new small molecule PET-radiotracers for the molecular imaging of inflammatory processes targeting S100A9
|
Steiner, Simon |
|
|
76-77 |
S |
p. S44-S45 |
artikel |
276 |
Development and evaluation of novel TSPO PET tracers with low binding sensitivity to human single nucleotide polymorphism rs6971
|
Beaino, Wissam |
|
|
76-77 |
S |
p. |
artikel |
277 |
Development and evaluaton of a trans-cyclooctene (TCO) probe for pretargeted PET imaging
|
Adhikari, Karuna |
|
|
76-77 |
S |
p. S176 |
artikel |
278 |
Development and exploration of bifunctional chelating ligands for mercury-197m/g
|
Randhawa, Parmissa |
|
|
76-77 |
S |
p. S13-S14 |
artikel |
279 |
Development and First-in-Man Study of a Novel Tetrapeptidic CCK-2R-Targeted Compound with Improved Metabolic Stability and Pharmacokinetics
|
Günther, Thomas |
|
|
76-77 |
S |
p. |
artikel |
280 |
Development and initial evaluation of two [99mTc]Tc complexes derived from a fibroblast activating protein (FAP) inhibitor
|
Decuadra, Paula |
|
|
76-77 |
S |
p. S39-S40 |
artikel |
281 |
Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma
|
Métivier, Cassandra |
|
|
76-77 |
S |
p. S203-S204 |
artikel |
282 |
Development and in vivo Evaluation of a Novel 18F-labeled Aromatase Inhibitor PET Radiotracer in Rodent Models for Cancer
|
Li, Songye |
|
|
76-77 |
S |
p. |
artikel |
283 |
Development and preclinical evaluation of [11C]HSP990 as an Hsp90 PET brain probe and potential biomarker for diagnosis and follow up of CNS disease progression
|
Cools, Romy |
|
|
76-77 |
S |
p. S93-S94 |
artikel |
284 |
Development and pre-clinical evaluation of new 64Cu-NOTA-folate conjugates for PET imaging of folate receptor-positive tumors
|
Alhokbany, Norah |
|
|
76-77 |
S |
p. S74 |
artikel |
285 |
Development and preclinical evaluation of PSMA-targeting trimers based on the NOTI chelating platform
|
Martin, Sebastian |
|
|
76-77 |
S |
p. S41 |
artikel |
286 |
Development and preliminary evaluation of the fluorine-18 labeled benzamido-dihydroindene derivative [18F]FBAIN as a potential radiotracer for PET imaging of the chemokine receptor CXCR5
|
Lindemann, Marcel |
|
|
76-77 |
S |
p. S200-S201 |
artikel |
287 |
Development and radiolabelling of fluorinated ligands targetting the Aryl hydrocarbon Receptor
|
Vercouillie, Johnny |
|
|
76-77 |
S |
p. |
artikel |
288 |
Development and Radiosynthesis of [11C]MODAG-005 for in vivo Imaging of alpha-synuclein Pathology
|
Maurer, Andreas |
|
|
76-77 |
S |
p. |
artikel |
289 |
Development and validation of [18F]FDG dual radiosynthesis on a MX cassette with a NEPTIS® module
|
Joyard, Yoann |
|
|
76-77 |
S |
p. S128 |
artikel |
290 |
Development of a Candidate PET Radioligand for Receptor Interacting Protein 1 Kinase (RIPK1) and Evaluation in Healthy Monkey
|
Jana, Susovan |
|
|
76-77 |
S |
p. |
artikel |
291 |
Development of a 64Cu-labeled immuno-PET probe for imaging Sialyl Lewis X in breast cancer
|
Kaur, Jatinder |
|
|
76-77 |
S |
p. S221 |
artikel |
292 |
Development of a dual imaging probe for bimodal PET/ two-photon NIRF imaging
|
Jouad, Kamal |
|
|
76-77 |
S |
p. S167-S168 |
artikel |
293 |
Development of a [18F]PD-L1 radiotracer to profile cancer patient response to immunotherapy
|
Zecca, Henry |
|
|
76-77 |
S |
p. S189 |
artikel |
294 |
Development of a highly hydrophilic 18F-tetrazine for pre-targeting approaches in PET imaging
|
Perrio, Cecile |
|
|
76-77 |
S |
p. S84 |
artikel |
295 |
Development of a highly specific 18F-labeled benzimidazolone-based sigma-2 receptor radioligand for brain tumor imaging
|
Huang, Henry |
|
|
76-77 |
S |
p. |
artikel |
296 |
Development of aliphatic 18F-labeled tetrazines suitable for pretargeted PET imaging
|
Battisti, Umberto |
|
|
76-77 |
S |
p. S178-S179 |
artikel |
297 |
Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC
|
Hooijman, Eline |
|
|
76-77 |
S |
p. S22-S23 |
artikel |
298 |
Development of a 99mTc-NTP 15-5 kit for an early clinical trial
|
Sophie, Levesque |
|
|
76-77 |
S |
p. S145 |
artikel |
299 |
Development of a [99mTc]Tc-PVP nanogel for controlled release of 5-FU
|
Ges-Naranjo, Adrian |
|
|
76-77 |
S |
p. S84-S85 |
artikel |
300 |
Development of an effective electro-amalgamation technique to debulk Eu(III) from Eu(III)/Tb(III) mixtures: Towards future application in the separation of 155Tb from alpha-irradiated 153Eu
|
Serasinghe, Madhushan |
|
|
76-77 |
S |
p. |
artikel |
301 |
Development of a new class of Mn(II) complexes for MRI applications
|
Boschi, Alessandra |
|
|
76-77 |
S |
p. S69-S70 |
artikel |
302 |
Development of a New 64Cu-Semicarbazone Complex: Potential Theragnostic Radiopharmaceutical for Hypoxic Tumor
|
Alhokbany, Norah |
|
|
76-77 |
S |
p. |
artikel |
303 |
Development of a new reagent for 18F-trifluoroethylation of secondary amine
|
Choi, Ji Young |
|
|
76-77 |
S |
p. |
artikel |
304 |
Development of an 18F-labeled MutT Homolog 1 (MTH1) radiotracer ([18F]WC-7-73): synthesis, radiosynthesis and evaluation
|
Chu, Wenhua |
|
|
76-77 |
S |
p. |
artikel |
305 |
Development of an in-house 188W/188Re generator for rhenium-188 production and radiolabelling studies
|
Melis, Diana |
|
|
76-77 |
S |
p. S38 |
artikel |
306 |
Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging
|
Chen, Jiahui |
|
|
76-77 |
S |
p. |
artikel |
307 |
Development of a novel carbon-11 radiotracer for brain PET imaging of sulfonylurea receptors 1
|
Caillé, Fabien |
|
|
76-77 |
S |
p. S33-S34 |
artikel |
308 |
Development of a novel 68Ga-labeled benzo[h]quinoline-based FAP-targeted PET tracer: Synthesis, preclinical evaluation, and comparison with [68Ga]Ga-FAPI-04
|
Lin, Kuo-Shyan |
|
|
76-77 |
S |
p. |
artikel |
309 |
Development of a novel PET ligand for imaging AMPA receptor
|
Chen, Jiahui |
|
|
76-77 |
S |
p. |
artikel |
310 |
Development of a novel PET tracer for imaging of γ-8 dependent transmembrane AMPA receptor regulatory protein
|
Yu, Qingzhen |
|
|
76-77 |
S |
p. S66-S68 |
artikel |
311 |
Development of a novel reversible monoacylglycerol lipase PET tracer bearing a morpholine-3-one scaffold
|
He, Yingfang |
|
|
76-77 |
S |
p. S5-S6 |
artikel |
312 |
Development of Approaches for High-Throughput Experimentation in Radiochemistry
|
Webb, Eric |
|
|
76-77 |
S |
p. |
artikel |
313 |
Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy
|
Payne, Rachel |
|
|
76-77 |
S |
p. |
artikel |
314 |
Development of a radiolabeled self-assembled nanoparticle as an imaging probe for CD44-expressing tumors
|
Tanaka, Toshie |
|
|
76-77 |
S |
p. S83-S84 |
artikel |
315 |
Development of a radiotheranostics agent with albumin binder aiming to increase the therapeutic effects for At-211 labeled RGD peptide
|
Echigo, Hiroaki |
|
|
76-77 |
S |
p. |
artikel |
316 |
Development of a (+)RESCA-triaryl phosphine for in vitro radiolabeling using the Staudinger ligation
|
Biti, Anisa |
|
|
76-77 |
S |
p. |
artikel |
317 |
Development of a small-molecule CXCR3 PET radiotracer for atherosclerosis imaging in live animals
|
Alluri, Santosh Reddy |
|
|
76-77 |
S |
p. S17 |
artikel |
318 |
Development of a stabilized GRPR antagonist for targeted cancer theranostics
|
Abouzayed, Ayman |
|
|
76-77 |
S |
p. S24 |
artikel |
319 |
Development of a stable peptide-based PET tracer for detecting CD133-expressing cancer cells
|
Hu, Kuan |
|
|
76-77 |
S |
p. S195 |
artikel |
320 |
Development of Astatine-211 labeling reaction using aryliodonium ylide
|
Ogawa, Mikako |
|
|
76-77 |
S |
p. |
artikel |
321 |
Development of automatic synthesis method for [18F]Fluoromethyl-PBR28 using two synthesizer
|
Cho, Yong-Hyun |
|
|
76-77 |
S |
p. S123 |
artikel |
322 |
Development of bispecific theranostic ligand targeting the prostate specific membrane antigen (PSMA) and gastrin releasing peptide (GRPR) receptor
|
Bouzioti, Danai |
|
|
76-77 |
S |
p. S29-S30 |
artikel |
323 |
Development of BODIPY-Tetrazines as Pretargeted Bimodal Fluorescent-Radioactive Tracers
|
Herth, Matthias |
|
|
76-77 |
S |
p. |
artikel |
324 |
Development of CD44-targeted 64Cu-labeled peptide for diagnosis of cancer stem cells
|
Eom, Sairan |
|
|
76-77 |
S |
p. |
artikel |
325 |
Development of C-terminal modified long-acting DOTA-JR11 analogs for optimized treatment of NETs
|
Handula, Maryana |
|
|
76-77 |
S |
p. |
artikel |
326 |
Development of 11C-Tucatinib as a potential HER2-targeting PET radiotracer
|
Müller, Marius |
|
|
76-77 |
S |
p. S206 |
artikel |
327 |
Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer
|
Seo, Hye Yeon |
|
|
76-77 |
S |
p. S61 |
artikel |
328 |
Development of discoidal phospholipid bilayer nanoparticles with styrene maleic acid copolymer for diagnosis and therapy of intractable cancers
|
Munekane, Masayuki |
|
|
76-77 |
S |
p. S83 |
artikel |
329 |
Development of FAP targeted radiopharmaceuticals
|
Xu, Mengxin |
|
|
76-77 |
S |
p. S221 |
artikel |
330 |
Development of [18F]Fluoromannitol, a Novel Radiopharmaceutical for Infection Imaging
|
Simpson, Spenser |
|
|
76-77 |
S |
p. |
artikel |
331 |
Development of [18F]fluoro-4-(vinylsulfonyl)benzene for chemoselective cysteine radiofunctionalization of peptides
|
McDaniel, James |
|
|
76-77 |
S |
p. S75-S76 |
artikel |
332 |
Development of finely tuned liposome nanoplatform for effective macrophage targeting and depletion
|
Choi, Tae Hyeon |
|
|
76-77 |
S |
p. |
artikel |
333 |
Development of five Polar and Highly Reactive Tetrazines for Pretargeted Imaging
|
Müller, Marius |
|
|
76-77 |
S |
p. |
artikel |
334 |
Development of 18F-labeled agonist for imaging STING in the tumor microenvironment
|
Liu, Huanhuan |
|
|
76-77 |
S |
p. S19-S20 |
artikel |
335 |
Development of 18F-Labeled tetrazines for pretargeted imaging across the blood-brain barrier
|
Shalgunov, Vladimir |
|
|
76-77 |
S |
p. S103-S104 |
artikel |
336 |
Development of 18F-labeled tracer for noninvasive PET imaging of the STING expression in tumor microenvironment
|
Fang, Jianyang |
|
|
76-77 |
S |
p. S187-S188 |
artikel |
337 |
Development of 18F-Labelled CXCR4-Targeted Peptide Radiopharmaceuticals Through Strain-Promoted Click Chemistry
|
Mason, Julia |
|
|
76-77 |
S |
p. |
artikel |
338 |
Development of freeze-dried kit for one-step expeditious preparation of [99mTc]Tc-PSMA-T4
|
Wojdowska, Wioletta |
|
|
76-77 |
S |
p. S146 |
artikel |
339 |
Development of freeze-dried kits for one-step expeditious formulation of [68Ga]Ga-NODAGA-JR11
|
Satpati, Drishty |
|
|
76-77 |
S |
p. S47 |
artikel |
340 |
Development of [68Ga]Ga-DOTA-4AH29, a radiolabeled single-domain antibody for PET imaging of FAP-α expression in cancer
|
Berdal, Marion |
|
|
76-77 |
S |
p. |
artikel |
341 |
Development of 68Ga-labeled riboflavin analognes for RFVTs-targeted PET imaging
|
Chen, Yingxi |
|
|
76-77 |
S |
p. |
artikel |
342 |
Development of gallium coordinate nonapeptides as candidates for PET imaging of neuropeptide Y1 receptors in oncology
|
Hetsron, Amit |
|
|
76-77 |
S |
p. S116 |
artikel |
343 |
Development of 125I-labeled tetrazines
|
Bidesi, Natasha |
|
|
76-77 |
S |
p. S52-S53 |
artikel |
344 |
Development of 123I-labelled acrylamides as radiotracer candidates for transglutaminase 2
|
Laube, Markus |
|
|
76-77 |
S |
p. S79-S80 |
artikel |
345 |
Development of liposome-based drug-releasing radiopharmaceutical for theranosis
|
Kim, Jiyoon |
|
|
76-77 |
S |
p. |
artikel |
346 |
Development of locally injectable thermo-sensitive polymer micelle using as carriers for combined radio- and chemotherapy of cancers
|
Makino, Akira |
|
|
76-77 |
S |
p. |
artikel |
347 |
Development of 99mTc-labeled hexavalent c(RGDfK) peptide with optimized linker structure for in vivo imaging of integrin αvβ3
|
Mizuno, Yuki |
|
|
76-77 |
S |
p. S7-S8 |
artikel |
348 |
Development of new aptamer-labeled radiopharmaceuticals
|
Ozerskaya, Anastasia |
|
|
76-77 |
S |
p. S43 |
artikel |
349 |
Development of novel 64Cu-labelled antibodies for PET-CT imaging of TREM2
|
Shojaei, Monireh |
|
|
76-77 |
S |
p. S104 |
artikel |
350 |
Development of novel PSMA target therapeutic radiopharmaceuticals by modification with albumin binder
|
Lee, Kyongkyu |
|
|
76-77 |
S |
p. S198-S199 |
artikel |
351 |
Development of novel sulfur-rich ligands for incorporation into mercury-197m/g radiopharmaceuticals
|
Randhawa, Parmissa |
|
|
76-77 |
S |
p. S8 |
artikel |
352 |
Development of novel tripodal chelates for the stable chelation of theranostic radiolanthanides and actinides
|
Carbo-Bague, Imma |
|
|
76-77 |
S |
p. S148 |
artikel |
353 |
Development of 203Pb-labeled SSTR2 radioligands for neuroendocrine tumors (NETs) imaging
|
Chapeau, Dylan |
|
|
76-77 |
S |
p. S54-S55 |
artikel |
354 |
Development of peptide probes for imaging of CD206 positive macrophages in cancer
|
Zhang, Bo |
|
|
76-77 |
S |
p. S40 |
artikel |
355 |
Development of PSMA-targeted vectors containing an albumin binder and a cleavable linker
|
Murce, Erika |
|
|
76-77 |
S |
p. S48-S49 |
artikel |
356 |
Development of (radio)fluorinated aminobenzothiazole derivatives as potential adenosine A2A receptor ligands
|
Renk, Dana |
|
|
76-77 |
S |
p. S100-S101 |
artikel |
357 |
Development of radio-halogen-labeled PSMA-targeting ligand with high in vivo stability
|
Yamashita, Tomoki |
|
|
76-77 |
S |
p. |
artikel |
358 |
Development of radiolabeled polymer nano- and micron-sized carriers
|
Muslimov, Albert |
|
|
76-77 |
S |
p. S86-S87 |
artikel |
359 |
Development of reversible monoacylglycerol lipase PET tracers with improved brain uptake
|
He, Yingfang |
|
|
76-77 |
S |
p. S36 |
artikel |
360 |
Development of silicon fluoride acceptor (SiFA)-conjugated antibodies targeting TREM2 and Poly-GA repeats as new tracers for PET imaging of neurodegenerative diseases
|
Shojaei, Monireh |
|
|
76-77 |
S |
p. S37 |
artikel |
361 |
Development of site-specifically labelled single-domain antibody PET probe for monitoring PD-L1 expression in cancer
|
Chen, Yinfei |
|
|
76-77 |
S |
p. S200 |
artikel |
362 |
Development of small molecule PET-tracers targeting PD-L1
|
Bamminger, Karsten |
|
|
76-77 |
S |
p. |
artikel |
363 |
Development of Solid Target Technologies for 225Ac Production with Proton Bombardment
|
Malinconico, Mario |
|
|
76-77 |
S |
p. |
artikel |
364 |
Development of targeted 161Tb-radiolabeled nanoparticles
|
Lemaître, Tom |
|
|
76-77 |
S |
p. S69 |
artikel |
365 |
Development of Terbium-161 Based VLA-4 Targeted Theranostics
|
Iweha, Ejike |
|
|
76-77 |
S |
p. |
artikel |
366 |
Development of two [99mTc]Tc(CO)3 complexes targeting the androgen receptor
|
Decuadra, Paula |
|
|
76-77 |
S |
p. S38-S39 |
artikel |
367 |
Development of versatile dual-modality imaging probes based on a GRPR antagonist for preoperative imaging and image-guided surgery of prostate cancer
|
Handula, Maryana |
|
|
76-77 |
S |
p. S82 |
artikel |
368 |
Development of 89Zr-antibody-PET imaging to evaluate improved brain targeting via transferrin receptor 1: the chelator matters
|
Wuensche, Thomas |
|
|
76-77 |
S |
p. S24 |
artikel |
369 |
Development of 89Zr-radiolabeled paclitaxel-loaded polymeric micelles for potential applications in personalized treatment of triple-negative breast cancer
|
Sadeghzadeh, Masoud |
|
|
76-77 |
S |
p. S163-S164 |
artikel |
370 |
Diagnostic efficacy of 68Ga-DOTAGA-Duramycin for early detection of anthracycline induced cardiotoxicity in Wistar rats
|
Gill, Gurvinder |
|
|
76-77 |
S |
p. S65-S66 |
artikel |
371 |
Differential and staging diagnosis for NSCLC patients With [68Ga] Ga-DOTA-FAPI-04 and 2-[18F]FDG PET/CT
|
Zhou, Xin |
|
|
76-77 |
S |
p. S46-S47 |
artikel |
372 |
Diphosphine bifunctional chelators: [99mTc][TcO2(DP-PSMAt)2]+ tracers for PSMA imaging of prostate cancer
|
Hungnes, Ingebjorg |
|
|
76-77 |
S |
p. S5-S6 |
artikel |
373 |
Direct carbon-11 isotopic radiolabeling of Domperidone from [11C]CO2: application to in vivo brain PET imaging under P-glycoprotein inhibition
|
Caillé, Fabien |
|
|
76-77 |
S |
p. S91 |
artikel |
374 |
Direct clinical comparison of scaffold proteins [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 for imaging of HER2-positive breast cancer
|
Tolmachev, Vladimir |
|
|
76-77 |
S |
p. |
artikel |
375 |
Direct 11C-methylation of amines using cyclotron-produced [11C] CO2
|
Kealey, Steven |
|
|
76-77 |
S |
p. S30 |
artikel |
376 |
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: antagonist versus agonist
|
Cleeren, Frederik |
|
|
76-77 |
S |
p. |
artikel |
377 |
Direct 18F fluorination of covalent organic framework (COF) nanosheets for PET molecular imaging
|
Kim, Dong Wook |
|
|
76-77 |
S |
p. S161-S162 |
artikel |
378 |
Direct 18F-labeling of a dimeric RGD peptide via F-nucleophilic substitution on a phosphonate prothesis
|
Wang, Chao |
|
|
76-77 |
S |
p. S76 |
artikel |
379 |
Discovery of [18F]F-687-TCO: An Optimized Tracer for Pretargeted PET Imaging in the CNS
|
Cook, Brendon |
|
|
76-77 |
S |
p. |
artikel |
380 |
Discovery, preclinical validation and early human imaging with [11C]AZ14193391 – the first blood-brain barrier permeable and subtype selective PARP1 PET radioligand
|
Cortes Gonzalez, Miguel Angel |
|
|
76-77 |
S |
p. |
artikel |
381 |
DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy
|
Piron, Bérengère |
|
2014 |
76-77 |
S |
p. e75-e83 nvt p. |
artikel |
382 |
DOTA derivatives with sulfur containing side chains as an attempt to thwart the biological instability of copper labelled radiotracers
|
Tosato, Marianna |
|
|
76-77 |
S |
p. S6-S7 |
artikel |
383 |
DOX-PEG-198AuNPs-PEG-Tmab: multimodal radiobioconjugate for targeted radionuclide therapy of HER2-positive cancers
|
Zelechowska-Matysiak, Kinga |
|
|
76-77 |
S |
p. S165-S166 |
artikel |
384 |
Dual labelling platform for theranostics: PSMA-targeted imaging with 99mTc and therapy with 188Re
|
Hungnes, Ingebjorg |
|
|
76-77 |
S |
p. |
artikel |
385 |
Dual PET imaging of microtubule destabilization and synaptic integrity in a mouse model of AD
|
Damuka, Naresh |
|
|
76-77 |
S |
p. |
artikel |
386 |
Dual targeting of PD-L1 and integrin avb3 with a peptide tracer
|
Hu, Kuan |
|
|
76-77 |
S |
p. |
artikel |
387 |
Economical radiosynthesis optimization using a multi-reaction microdroplet chip platform
|
Rios, Alejandra |
|
|
76-77 |
S |
p. S65-S66 |
artikel |
388 |
Editorial Board
|
|
|
|
76-77 |
S |
p. i |
artikel |
389 |
Editorial Board
|
|
|
|
76-77 |
S |
p. ii |
artikel |
390 |
Editorial Board
|
|
|
2014 |
76-77 |
S |
p. IFC- 1 p. |
artikel |
391 |
Editorial Board
|
|
|
|
76-77 |
S |
p. i |
artikel |
392 |
Editorial Board
|
|
|
|
76-77 |
S |
p. |
artikel |
393 |
Effect of dissolution and exposure of [18F]F– on nucleophilic 18F-fluorination
|
Mou, Zhaobiao |
|
|
76-77 |
S |
p. S77-S78 |
artikel |
394 |
Effect of (2-hydroxypropyl)-β-cyclodextrin on the solubility and in vivo behavior of the myocardial perfusion imaging agent [18F] FRho6G-DEG
|
Inkster, James |
|
|
76-77 |
S |
p. S58 |
artikel |
395 |
Effect of metal impurities on the radiolabeling efficiency of DOTA with terbium-161 and lutetium-177: a comparative study
|
Opsomer, Tomas |
|
|
76-77 |
S |
p. S57-S58 |
artikel |
396 |
Effects of linker and binding motif modifications on tumor uptake and distribution of 99mTc-labeled HYNIC-based PSMA-targeting SPECT tracers
|
Lu, Kelly |
|
|
76-77 |
S |
p. |
artikel |
397 |
Effects of Polyethylene Glycol and 8-Aminooctanoic Acid Linkers on Melanoma Uptake of [99mTc]-Tricarbonyl-NOTA-Conjugated Lactam-Cyclized Alpha-MSH Peptides
|
Qiao, Zheng |
|
|
76-77 |
S |
p. |
artikel |
398 |
Effects of solvents on the yield of 6-bromo-7-[11C]methylpurine
|
Okamura, Toshimitsu |
|
|
76-77 |
S |
p. |
artikel |
399 |
Effects of uncharged linker-modification of PSMA-617-based inhibitors on targeting properties and the pharmacokinetic profile
|
Geis, Nicolas |
|
|
76-77 |
S |
p. |
artikel |
400 |
Efficacy and imaging evaluation of 177Lu-labeled antibody-drug conjugates as a potential theranostic agent for HER2-positive breast cancer
|
Kim, Heejung |
|
|
76-77 |
S |
p. S104-S105 |
artikel |
401 |
Efficient and cGMP-Compliant Manufacturing of C-11 PIB using Sep-Pak: A single cassette module approach for multiple productions
|
Nair, Manoj |
|
|
76-77 |
S |
p. |
artikel |
402 |
Efficient and mild copper-labelling of sensitive targeting vectors with novel triazamacrocyclic chelator
|
Hierlmeier, Ina |
|
|
76-77 |
S |
p. |
artikel |
403 |
Efficient cartridge-based synthesis of a novel [18F]tetrazine for large molecule labelling
|
Rokka, Johanna |
|
|
76-77 |
S |
p. S115 |
artikel |
404 |
Efficient chelation of 134Ce/La using the macrocyclic chelators DOTA and Macropa as potential PET imaging agents
|
Bobba, Kondapa |
|
|
76-77 |
S |
p. S8-S9 |
artikel |
405 |
Efficient 18F-fluorination for dimorpholinophosphinic fluoride
|
Wang, Tao |
|
|
76-77 |
S |
p. S79 |
artikel |
406 |
Efficient radiosynthesis of a new folate receptor-targeting PET tracer, [18F]fluoronicotinic acid labeled folate, for imaging lung fibrosis
|
Zhuang, Xiaoqing |
|
|
76-77 |
S |
p. |
artikel |
407 |
EGSnrc Monte Carlo calculated dose distribution around brachytherapy sources
|
Tuan, Hoang |
|
|
76-77 |
S |
p. S175-S176 |
artikel |
408 |
Electronic cigarette aerosol deposition of [11C]nicotine in human subjects: radiosynthesis and vaping apparatus development
|
VanBrocklin, Henry |
|
|
76-77 |
S |
p. S137-S138 |
artikel |
409 |
Electrophilic Synthesis of 6-L-[18F]FDOPA with [18F]F2: a progress report on gas target of Cyclotron TR-Flex
|
Kniess, Torsten |
|
|
76-77 |
S |
p. |
artikel |
410 |
Enabling insights into the cytochrome P450 isoform specific metabolism of radiotracers by CYP overexpressing hepatoblastoma cell lines
|
Lemm, Sandy |
|
|
76-77 |
S |
p. S66-S67 |
artikel |
411 |
Enantioselective Synthesis and Biological Evaluation of (R)- and (S)-[18F]OF-NB1 to Visualize GluN2B Subunit-Containing NMDA Receptors
|
Rong, Jian |
|
|
76-77 |
S |
p. |
artikel |
412 |
ENBPI ligand for 68Ga: synthesis, radiolabeling optimization, and pilot myocardial perfusion imaging with ECG-gated PET
|
Muzzioli, Riccardo |
|
|
76-77 |
S |
p. S57 |
artikel |
413 |
Enhanced blood retention and tumor uptake of PSMA-targeting, 225Ac-labeled radioconjugates
|
Reissig, Falco |
|
|
76-77 |
S |
p. S30-S31 |
artikel |
414 |
Epigenetic modifiers in somatostatin type 2 receptor radionuclide theranostics and early transcriptional response of mouse pheochromocytoma models
|
Ullrich, Martin |
|
|
76-77 |
S |
p. S11 |
artikel |
415 |
Establishing the host-guest pretargeting platform with adamantane guest ligands in a xenograft model
|
Jallinoja, Vilma |
|
|
76-77 |
S |
p. S18-S19 |
artikel |
416 |
Establishing the role of “Design of Experiments” (DoE) in the tracer development pipeline: the synthesis and evaluation of [18F] talazoparib as a case study
|
Bowden, Gregory |
|
|
76-77 |
S |
p. S78-S79 |
artikel |
417 |
Evaluating the effect of an albumin binder for targeting melanoma tumors with 89Zr-Lumi804-Lys-pIBA-PEG4-LLP2A
|
Fong, Cyril |
|
|
76-77 |
S |
p. |
artikel |
418 |
Evaluating the Interplay of 89Zr-labeled Radioimmunoconjugates and Fc Receptors in Genetically Engineered Mouse Models
|
Rodriguez, Cindy |
|
|
76-77 |
S |
p. |
artikel |
419 |
Evaluating the in vivo distribution and stability of a 161Tb-labeled nanobody for potential cancer therapy
|
Cassells, Irwin |
|
|
76-77 |
S |
p. S50 |
artikel |
420 |
Evaluating the potential of CCR2 for the early detection of head and neck cancer
|
Kang, Yeona |
|
|
76-77 |
S |
p. |
artikel |
421 |
Evaluating the radionuclide theranostic potential of a MUC13-targeting antibody in colorectal cancer
|
Coll, Ryan |
|
|
76-77 |
S |
p. |
artikel |
422 |
Evaluation of Actinium-225 radiolabeled cyclized alpha-melanocyte stimulating hormone (CycMSH) peptide for targeted alpha therapy
|
Brown, Victoria |
|
|
76-77 |
S |
p. S101 |
artikel |
423 |
Evaluation of Affibody molecule Z09591 for PET imaging in fibrosis
|
Wegrzyniak, Olivia |
|
|
76-77 |
S |
p. S44 |
artikel |
424 |
Evaluation of a multifunctional blood-brain barrier co-culture model prepared from rat primary brain endothelial cells and astrocytes: first results
|
Schneider, Daniela |
|
|
76-77 |
S |
p. S102-S103 |
artikel |
425 |
Evaluation of an open-source 3D printed microfluidic system for the production of radiopharmaceuticals
|
Cotton, Jonathan |
|
|
76-77 |
S |
p. S123-S124 |
artikel |
426 |
Evaluation of a Radiofluorinated Probe for Imaging Cytochrome P450 46A1
|
Zhao, Chunyu |
|
|
76-77 |
S |
p. |
artikel |
427 |
Evaluation of biodistribution of a novel sugar-conjugated platinum complex labeled with 191Pt in mice
|
Omokawa, Marina |
|
|
76-77 |
S |
p. |
artikel |
428 |
Evaluation of 134Ce/La pair as a PET imaging surrogate for 225Ac radiotherapeutics
|
Bobba, Kondapa |
|
|
76-77 |
S |
p. |
artikel |
429 |
Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours
|
Narykina, Valeria |
|
|
76-77 |
S |
p. S207-S208 |
artikel |
430 |
Evaluation of 64Cu-labeled DOTA-polymer functionalized peptides
|
Villas Boas, Cristian Wieczorek |
|
|
76-77 |
S |
p. S63-S64 |
artikel |
431 |
Evaluation of [18F]FPy-T140 derivative PET imaging agents for CXCR4 in human cancer xenograft mouse models
|
Phelps, Tim |
|
|
76-77 |
S |
p. S20 |
artikel |
432 |
Evaluation of 18F-Labelled Radiotracers for Imaging of Sigma-2 Receptor in the Brain of Nonhuman Primates
|
Wenn, Mike |
|
|
76-77 |
S |
p. |
artikel |
433 |
Evaluation of [18F]RM273 for sigma2-receptor imaging in an experimental orthotopic glioblastoma model
|
Guendel, Daniel |
|
|
76-77 |
S |
p. S184 |
artikel |
434 |
Evaluation of in vivo behavior of Na[F-18]F as a single substance and Na[F-18]F-contained mouthwashes via intra-trachea instillation
|
Kim, Dong Hyun |
|
|
76-77 |
S |
p. |
artikel |
435 |
Evaluation of Iododiflunisal on amyloid-β deposition in 5xFAD Alzheimer’s disease mouse model by Positron Emission Tomography imaging.
|
Zapero, Claudia Esposito |
|
|
76-77 |
S |
p. |
artikel |
436 |
Evaluation of kit-based synthesis and delivery of 99mTc zoledronic acid as bone cancer imaging radiopharmaceutical
|
Ng, Yen |
|
|
76-77 |
S |
p. S208 |
artikel |
437 |
Evaluation of 3,4,3-LI(1,2-HOPO) as a chelator for radioscandium based radiopharmaceuticals
|
Phipps, Michael |
|
|
76-77 |
S |
p. S155-S156 |
artikel |
438 |
Evaluation of lysine modifications in the PSMA-targeting pharmacophore using positron emission tomography imaging in a preclinical model of human prostate cancer
|
Zhang, Chengcheng |
|
|
76-77 |
S |
p. |
artikel |
439 |
Evaluation of neuroinflammatory radiotracers in chronic traumatic encephalopathy
|
Varlow, Cassis |
|
|
76-77 |
S |
p. S109 |
artikel |
440 |
Evaluation of 3p-C-DEPA as potential 225Ac-chelator
|
Ahenkorah, Stephen |
|
|
76-77 |
S |
p. S49 |
artikel |
441 |
Evaluation of PET-based Human Biodistribution of a Novel Amino Acid 11C-MeLeu PET/CT Imaging in Normal Volunteers
|
Nishii, Ryuichi |
|
|
76-77 |
S |
p. |
artikel |
442 |
Evaluation of polyazamacrocycles functionalized with sulphur-containing pendant arms as potential chelators for theranostic silver-111
|
Tosato, Marianna |
|
|
76-77 |
S |
p. S158 |
artikel |
443 |
Evaluation of Pyridyl Benzofuran Derivative for Targeted Alpha Therapy of Alzheimer’s Disease
|
Bender, Aidan |
|
|
76-77 |
S |
p. |
artikel |
444 |
Evaluation of (R)- and (S)-18F-PF-NB1 in non-human primates for imaging the GluN2B subunits of NMDA receptor complex
|
Wenn, Mike |
|
|
76-77 |
S |
p. |
artikel |
445 |
Evaluation of [47Sc]Sc-HOPO toward radioscandium based radiopharmaceuticals
|
Phipps, Michael |
|
|
76-77 |
S |
p. S91-S92 |
artikel |
446 |
Evaluation of selective Sc(III) complexes with a non-macrocyclic ligand for theranostics applications
|
Huclier, Sandrine |
|
|
76-77 |
S |
p. S56 |
artikel |
447 |
Evaluation of tetramethylammonium salts in minimalist-like SNAr radiofluorinations
|
Humpert, Swen |
|
|
76-77 |
S |
p. |
artikel |
448 |
Evaluation of the binding characteristics of [18F]FBVM in non-human primates, a new radiotracer for imaging the vesicular acetylcholine transporter in vivo using positron emission tomography
|
Serriere, Sophie |
|
|
76-77 |
S |
p. S94-S95 |
artikel |
449 |
Evaluation of the combinationally glycated albumin nanoplatform for targeting the tumor microenvironment with minimized reticuloendothelial system uptake using PET imaging
|
Kim, JinSil |
|
|
76-77 |
S |
p. |
artikel |
450 |
Evaluation of the effect of macrocyclic ring size on Pb(II) and Cu(II) complex stability in pyridyl containing chelators
|
McNeil, Brooke |
|
|
76-77 |
S |
p. S154 |
artikel |
451 |
Evaluation of the effects of conjugation chemistry and different LET radionuclides in prostate cancer xenograft
|
Strand, Joanna |
|
|
76-77 |
S |
p. |
artikel |
452 |
Evaluation of the therapeutic effect of taurine against Alzheimer’s disease using mGluR5 PET
|
Lee, Kyo Chul |
|
|
76-77 |
S |
p. S93 |
artikel |
453 |
Evaluation of the tumour targeting profile and characterisation of the metabolites for a novel stabilised minigastrin analogue
|
Hörmann, Anton |
|
|
76-77 |
S |
p. S194-S195 |
artikel |
454 |
Evaluation of tin dioxide as an inorganic-based stationary phase for a potential 44Ti/44Sc generator
|
Deri, Melissa |
|
|
76-77 |
S |
p. S43 |
artikel |
455 |
Evaluation of 44Ti/44Sc generator and 44Sc-post-processing procedures for radiopharmaceutical purposes: [44Sc]Sc-PSMA-617 and [44Sc]Sc-PSMA-I&T synthesis
|
Larenkov, Anton |
|
|
76-77 |
S |
p. S152 |
artikel |
456 |
Examination of bifunctional chelates for efficient labeling of affibodies with 52Mn
|
Brezovcsik, Karoly |
|
|
76-77 |
S |
p. S147-S148 |
artikel |
457 |
Examining the synergistic effect of radioimmunotherapy and immune checkpoint blockade for the treatment of metastatic melanoma
|
Allen, Kevin |
|
|
76-77 |
S |
p. S33 |
artikel |
458 |
Expanding the radiochemist’s toolbox: carbon-11 labelled formamides and isocyanides for PET tracer synthesis
|
Bonnemaire, Coralie |
|
|
76-77 |
S |
p. S10 |
artikel |
459 |
Experience on clinical scale formulation of ready to use [90Y] Y-hydroxyapatite microparticles utilizing 90Y produced in research reactor
|
Chakraborty, Sudipta |
|
|
76-77 |
S |
p. S140 |
artikel |
460 |
Exploration of 99Tc pincer-type complexes interacting with small molecules
|
Besmer, Manuel |
|
|
76-77 |
S |
p. S6 |
artikel |
461 |
Exploration of the fundamental chemistries of Ru and Pd for establishing 103Ru/103mRh Auger generator and 103Pd/103mRh in vivo generator
|
Thery, Marie |
|
|
76-77 |
S |
p. S150-S151 |
artikel |
462 |
Exploration the fluorine chemistry to develop the [18F]FS1P1 as a promise F-18 radiotracer for imaging S1PR1 in vivo
|
Qiu, Lin |
|
|
76-77 |
S |
p. S11-S12 |
artikel |
463 |
Exploring a Tristhione Scorpionate Ligand as a Suitable Chelator for the Theranostic Pair Antimony-119 and Antimony-117
|
Gé, Lorraine |
|
|
76-77 |
S |
p. |
artikel |
464 |
Exploring bpcd ligand for theranostic radiopharmaceutical application
|
Cazzola, Emiliano |
|
|
76-77 |
S |
p. S54 |
artikel |
465 |
Exploring new strategies for technetium radiolabeled [1,2,4,5] tetrazines
|
Rodriguez, Gonzalo |
|
|
76-77 |
S |
p. S60-S61 |
artikel |
466 |
Exploring the chemical scope of light-activated protein conjugation and the photoradiosynthesis of 89Zr-antibodies
|
Earley, Daniel |
|
|
76-77 |
S |
p. S94 |
artikel |
467 |
Exploring the potential of high-specific activity samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE
|
Vermeulen, Koen |
|
|
76-77 |
S |
p. S57 |
artikel |
468 |
Extracorporeal clearing traps based on tetrazine ligation for pretargeted therapy and diagnostics
|
Shalgunov, Vladimir |
|
|
76-77 |
S |
p. S212 |
artikel |
469 |
Extraction chromatographic separation of selenium and arsenic for accelerator target processing
|
Baumeister, Jakob |
|
|
76-77 |
S |
p. S92-S93 |
artikel |
470 |
Extraction of 68Ga medical radioisotopes from Zn nitrate liquid target using atomic layer deposited microfluidics
|
Santoso, Albert |
|
|
76-77 |
S |
p. |
artikel |
471 |
[18F]AlF and RESCA: a novel method for radiolabeling of Affibody molecules
|
Lechi, Francesco |
|
|
76-77 |
S |
p. |
artikel |
472 |
[18F]ALX5406: a brain-penetrating prodrug for GlyT1-specific PET imaging
|
Hoffmann, Chris |
|
|
76-77 |
S |
p. S45 |
artikel |
473 |
Fast, efficient, one-step purification of cyclotron produced lanthanum-135 using HDEHP-based resin and dilute hydrochloric acid
|
Nielsen, Karin Michaelsen |
|
|
76-77 |
S |
p. S18-S19 |
artikel |
474 |
18F-Chemistry in HPLC vials - a microliter scale radiofluorination approach
|
Laube, Markus |
|
|
76-77 |
S |
p. S61 |
artikel |
475 |
[18F]Difluorocarbene for positron emission tomography
|
Sap, Jeroen |
|
|
76-77 |
S |
p. |
artikel |
476 |
[18F]FEPPA PET imaging for monitoring the neuroinflammation status in a Lactacystin-induced Parkinson disease animal model.
|
Chiu, Ching-Hung |
|
|
76-77 |
S |
p. |
artikel |
477 |
[18F]FLUDA – A promising PET probe for the non-invasive assessment of the A2A adenosine receptor
|
Lai, Thu Hang |
|
|
76-77 |
S |
p. |
artikel |
478 |
18F-Fluorination Reactions and Optimizations using a Parallel Synthesis Reactor
|
Donat, Cornelius |
|
|
76-77 |
S |
p. |
artikel |
479 |
[18F]Fluoroform radiolabelling of the CHK1 inhibitor CCT245737
|
Sharma, Gitanjali |
|
|
76-77 |
S |
p. S48-S49 |
artikel |
480 |
3-[18F]Fluoro-5-hydroxy- and 3-[18F]fluorophenylserines: Preparation and initial biological evaluation
|
Kolks, Niklas |
|
|
76-77 |
S |
p. |
artikel |
481 |
5-[18F]Fluoro-m-tyrosine (5-[18F]FMT) - a novel promising tracer for dopaminergic imaging
|
Vus, Stefanie |
|
|
76-77 |
S |
p. S38 |
artikel |
482 |
[18F]FS-DPA: a novel PET probe for imaging of neuroinflammation easily accessible via SuFEx click labeling
|
Walter, Nils |
|
|
76-77 |
S |
p. S110 |
artikel |
483 |
18F-Functionalization of sulfur heteroatom frameworks via isotopic exchange in hydrous organic media
|
Kim, Min Pyeong |
|
|
76-77 |
S |
p. S37 |
artikel |
484 |
[18F]GP1, a novel PET tracer investigated for the detection of thrombi in LVADs and for the diagnosis of valve thrombosis
|
Hugenberg, Verena |
|
|
76-77 |
S |
p. |
artikel |
485 |
[18F]hGTS13 for imaging of xC − transporter activity in high-grade glioma
|
Kendrili, M. Tansel |
|
|
76-77 |
S |
p. |
artikel |
486 |
First experiences with the SST2R-antagonist [68Ga]Ga-DATA5m-LM4 for PET imaging of tumors: preclinical comparison with [68Ga] Ga-DOTA-LM3
|
Kanellopoulos, Panagiotis |
|
|
76-77 |
S |
p. S16-S17 |
artikel |
487 |
First-In-Class Diagnostics Targeting Neuropeptide Y1 Receptor (Y1R): Enabling Molecular Imaging of Metastatic Breast Cancer
|
Rahimi, Marwa Nadia |
|
|
76-77 |
S |
p. |
artikel |
488 |
First-in-human evaluation of [99mTc]Tc-(HE)3-G3, a novel DARPin-based agent for imaging of HER2 expression in breast cancer
|
Tolmachev, Vladimir |
|
|
76-77 |
S |
p. S17-S18 |
artikel |
489 |
First in-human studies of the glutamate transporter EAAT2 radiotracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparginate (RP-115): radiosynthesis and biodistribution evaluation
|
Nillo, Ryan Michael |
|
|
76-77 |
S |
p. |
artikel |
490 |
First microvolume metal-mediated synthesis of [18F]FDOPA in a microreactor
|
Lu, Yingqing |
|
|
76-77 |
S |
p. S15-S16 |
artikel |
491 |
First time evaluation of 45Ti for radiolabeling of NOTA and DOTA chelators
|
Milton, Stefan |
|
|
76-77 |
S |
p. |
artikel |
492 |
F-18 labeled azaindole derivatives as PET imaging tracer for tau protein
|
Kim, Dong Wook |
|
|
76-77 |
S |
p. |
artikel |
493 |
18F-labeled imidazole naphthyridine derivatives as Tau imaging agents in Alzheimer’s Disease
|
Liu, Tianqing |
|
|
76-77 |
S |
p. |
artikel |
494 |
18F-labeled indole-based analogs with chiral 2,3-dihydroxyfluorobutoxy side chain as highly selective sigma-2 receptor probes for tumor imaging
|
An, Xiaodan |
|
|
76-77 |
S |
p. S196-S197 |
artikel |
495 |
18F labelled albumin binding synthons enabling PET imaging and enhanced target accumulation of biomolecules
|
Hall, Andrew |
|
|
76-77 |
S |
p. S41-S42 |
artikel |
496 |
18F-Labelled inhibitors for targeting of IDH1 mutant gliomas
|
Neumaier, Bernd |
|
|
76-77 |
S |
p. |
artikel |
497 |
18F-labelled probes for non-invasive assessment of the IDH genotype in diffuse glioma
|
Cologni, Roberta |
|
|
76-77 |
S |
p. S17-S18 |
artikel |
498 |
Fluoride mediated radiosynthesis of [11C]methyl esters
|
Neelamegam, Ramesh |
|
|
76-77 |
S |
p. S73-S74 |
artikel |
499 |
Fluorinated PET imaging probes targeting fibroblast activation protein: radiolabeling and preclinical evaluation
|
Elvas, Filipe |
|
|
76-77 |
S |
p. S40-S41 |
artikel |
500 |
Fluorine-18 Labeling of Neutrophil Elastase Inhibitors
|
Holm, Linus Johansson |
|
|
76-77 |
S |
p. |
artikel |
501 |
Fluorine-mediated desilylative Carbon-11 carboxylation of acylsilanes with [11C]CO2 for the radiosynthesis of [1-11C]α-keto acids
|
Lee, Sanghee |
|
|
76-77 |
S |
p. |
artikel |
502 |
Fluoroquinolone dithiocarbamate rhenium and technetium-99m complexes for potential infection imaging agents
|
Shegani, Antonio |
|
|
76-77 |
S |
p. S98 |
artikel |
503 |
18F-microbubble for PET/US imaging: conception and in vivo imaging
|
Ariztia, Julen |
|
|
76-77 |
S |
p. S166-S167 |
artikel |
504 |
[18F]MK-7246 for Positron Emission Tomography imaging of beta cells surface marker GRP44
|
Cheung, Pierre |
|
|
76-77 |
S |
p. |
artikel |
505 |
Folate receptor targeted 64Cu/ICG-labeled layered double hydroxide nanoprobe for PET/CT and NIRF imaging
|
Lee, Kyo Chul |
|
|
76-77 |
S |
p. |
artikel |
506 |
Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers
|
Corlett, Alicia |
|
|
76-77 |
S |
p. S16-S17 |
artikel |
507 |
Formulation and evaluation of human clinical doses of 177Lu-labeled bisphosphonate amide of DOTA using lyophilized kits
|
Chakraborty, Sudipta |
|
|
76-77 |
S |
p. S99-S100 |
artikel |
508 |
[18F]OXD-2314: A 4R-Tau PET Radiotracer with Improved Affinity and Brain Uptake
|
Mason, Neale |
|
|
76-77 |
S |
p. |
artikel |
509 |
From R&D scale to clinical trial: design of 64Cu-radiolabeled compound production for phase I process
|
Drouin, Guillaume |
|
|
76-77 |
S |
p. S141-S142 |
artikel |
510 |
[18F]SuFEx-enabled access to an 18F-Labeled PSMA inhibitor intermediate
|
Craig, Austin |
|
|
76-77 |
S |
p. S81 |
artikel |
511 |
[18F]Talazoparib: a novel potential PET imaging agent of PARP
|
Muzzioli, Riccardo |
|
|
76-77 |
S |
p. S7-S8 |
artikel |
512 |
Fully automated and GMP-compliant synthesis of [18F]JK-PSMA-7 on a Trasis AllinOne module
|
Ermert, Johannes |
|
|
76-77 |
S |
p. S124 |
artikel |
513 |
Fully automated and GMP-compliant synthesis of [18F]SynVesT-1 on a Trasis AllinOne module
|
Ermert, Johannes |
|
|
76-77 |
S |
p. |
artikel |
514 |
Fully automated macro- and microfluidic production and physiological animal biodistribution of [68Ga]Ga-citrate
|
Ovdiichuk, Olga |
|
|
76-77 |
S |
p. S134-S135 |
artikel |
515 |
Fully Automated Production of [11C]ABP688, [11C]PS13, and [11C]PIB Using a TracerMaker Synthesis Module for Clinical Studies
|
Hu, Bao |
|
|
76-77 |
S |
p. |
artikel |
516 |
Fully automated purification of labelled antibody on PD-10 cartridges
|
Maindron, Nicolas |
|
|
76-77 |
S |
p. S131-S132 |
artikel |
517 |
Fully automated radiochemical synthesis of [68Ga]FAPI-4 and its preclinical evaluation for clinical translation
|
Sahu, Sudeep |
|
|
76-77 |
S |
p. S211-S212 |
artikel |
518 |
Fully Automated Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan ([18F]FETrp)
|
Jiang, Huailei |
|
|
76-77 |
S |
p. |
artikel |
519 |
Fully automated radiosynthesis of [18F]SMBT-1 for clinical use
|
Tago, Tetsuro |
|
|
76-77 |
S |
p. |
artikel |
520 |
Fully automated synthesis of [11C]nicotinamide for in vivo vitamin trafficking studies
|
Shegani, Antonio |
|
|
76-77 |
S |
p. S74-S75 |
artikel |
521 |
Functionality of a co-culture kidney model: testing the renal barrier with [18F]fluorodeoxyglucose
|
Sihver, Wiebke |
|
|
76-77 |
S |
p. |
artikel |
522 |
Functionalization and radiolabeling of M13 bacteriophages for PET imaging
|
Trommer, Johanna |
|
|
76-77 |
S |
p. |
artikel |
523 |
Future prospects for SPECT imaging using the radiolanthanide terbium-155 — production and preclinical evaluation in tumor-bearing mice
|
Müller, Cristina |
|
2014 |
76-77 |
S |
p. e58-e65 nvt p. |
artikel |
524 |
[68Ga]Ga-DOTA-C-glycosyl-RGD: synthesis, in vitro evaluation and PET imaging
|
Mengel, Emilien |
|
|
76-77 |
S |
p. S203 |
artikel |
525 |
[68Ga]Ga-DOTA-GIP1234 for PET imaging of glucose-dependent insulinotropic polypeptide receptor (GIPR)
|
Khalil, Amina |
|
|
76-77 |
S |
p. |
artikel |
526 |
[68Ga]Ga-HBED-CC-exendin-4: A new GLP1R targeting radiolabeled agent for pancreas β-cell and insulinoma imaging
|
Li, Linlin |
|
|
76-77 |
S |
p. S47-S48 |
artikel |
527 |
[68Ga]Ga-HBED-CC-FAPI derivatives with improved radiolabeling and specific tumor uptake
|
Li, Yuying |
|
|
76-77 |
S |
p. |
artikel |
528 |
[68Ga]Ga-NODAGA-TriGalactan a new PET-tracer for imaging of the functional liver reserve
|
Zierke, Maximilian |
|
|
76-77 |
S |
p. S65 |
artikel |
529 |
68Ga-labeled bivalent imaging agents targeting hypoxia and PSMA in tumors
|
Liu, Tianqing |
|
|
76-77 |
S |
p. |
artikel |
530 |
68Ga-labeled hypoxia and PSMA dual-targeting imaging agents
|
Liu, Tianqing |
|
|
76-77 |
S |
p. |
artikel |
531 |
68Ga-labeled Siderophores as Specific Radiotracers for Bacterial Infections
|
Al-Bazaz, Silav |
|
|
76-77 |
S |
p. |
artikel |
532 |
Ga-68-labelling of quinuclidine triazole-based compound
|
Kanasuwan, Apinan |
|
|
76-77 |
S |
p. S151-S152 |
artikel |
533 |
Gallium-68 and Copper-64 radiolabelling of hepatotropic GBVA10-9 or CPB peptide derivatives for hepatocellular carcinoma imaging
|
Brossard, Clarisse |
|
|
76-77 |
S |
p. S153 |
artikel |
534 |
68Ga-: 99mTc-labeled LHRH analog as new potential breast cancer imaging agents
|
Alfaya, Lucia |
|
|
76-77 |
S |
p. S49 |
artikel |
535 |
68Ga-radiolabeling of hepatitis E virus-like nanoparticles and evaluation of their ex vivo biodistribution in mice
|
Lambidis, Elisavet |
|
|
76-77 |
S |
p. S106-S107 |
artikel |
536 |
68Ga-radiolabeling reactions is a media of protic hydroxyalkylammonium ionic liquids based on diethanolammonium salts
|
Antuganov, Dmitrii |
|
|
76-77 |
S |
p. S96-S97 |
artikel |
537 |
68Ge/68Ga-generator: a radionuclide source or an approved drug?
|
Kvaternik, Herbert |
|
|
76-77 |
S |
p. S100 |
artikel |
538 |
Generation of 225Ac-DOTA-rituximab SPECT image from 64Cu-DOTA-rituximab PET image using unpaired image-to-image translation
|
Kim, Kangsan |
|
|
76-77 |
S |
p. |
artikel |
539 |
Genipin enhances 131I-rituximab induced cell cytotoxicity in lymphoma cells
|
Vinod, Nagarajan |
|
|
76-77 |
S |
p. S218 |
artikel |
540 |
GLP-1R targeting 68Ga-exendin-4 derivatives with lower renal retention for insulinomas and β-cell mass imaging
|
Liu, Tianqing |
|
|
76-77 |
S |
p. |
artikel |
541 |
Glucose-albumin nanoplatform for treating renal ischemia-reperfusion injury using reactive oxygen species scavenging properties
|
Park, Ji Yong |
|
|
76-77 |
S |
p. S163 |
artikel |
542 |
52gMn(II)-Labelled PSMA-ligands as bimodal PET/MR imaging probes
|
Strecker, Jonas |
|
|
76-77 |
S |
p. S157-S158 |
artikel |
543 |
GMP complaint production and quality control of a [99mTc]Tc-DTPA-GSA wet kit formulation
|
Denholt, Charlotte |
|
|
76-77 |
S |
p. |
artikel |
544 |
GMP compliant high-yield radiosynthesis of [18F]AlF-PSMA-11 on the IBA Synthera®+ Platform
|
Kersemans, Ken |
|
|
76-77 |
S |
p. |
artikel |
545 |
GMP-compliant radiosynthesis of [18F]GP1 for the detection of thrombi
|
Hugenberg, Verena |
|
|
76-77 |
S |
p. S66 |
artikel |
546 |
GMP-level production of radiometallated immune checkpoint inhibitor nivolumab: why and how?
|
Suchy, Mojmir |
|
|
76-77 |
S |
p. S61-S62 |
artikel |
547 |
GMP Production of Copper-64 for antibody and nanobody radiolabeling: liquid vs solid target
|
Hrynchak, Ivanna |
|
|
76-77 |
S |
p. |
artikel |
548 |
Halogen bond in the context of At-211 radiolabeling: the case of [211At]N-succinimidyl-3-astatobenzoate
|
Yssartier, Thibault |
|
|
76-77 |
S |
p. S159-S160 |
artikel |
549 |
Harnessing mushroom tyrosinase and the strain-promoted oxidation-controlled 1,2-quinone cycloaddition for the synthesis of site-specifically modified 89Zr-radioimmunoconjugates
|
Rodriguez, Cindy |
|
|
76-77 |
S |
p. S21-S22 |
artikel |
550 |
Harnessing the theranostic potential of lead radioisotopes with sulphur-containing macrocycles
|
Tosato, Marianna |
|
|
76-77 |
S |
p. S158-S159 |
artikel |
551 |
Harnessing 89Zr-PET to study the pulmonary clearance of microplastics in mice
|
Keinaenen, Outi |
|
|
76-77 |
S |
p. S55 |
artikel |
552 |
Head-to-head comparison of [18F]Florastamin, [18F]FDG PET/CT, and 99mTc-HDP bone scintigraphy in patients with prostate cancer
|
Lee, Inki |
|
|
76-77 |
S |
p. |
artikel |
553 |
Head-to-head Comparison of [18F]Florbetazine ([18F]92) and [11C] PiB in Alzheimer’s Disease
|
Li, Yuying |
|
|
76-77 |
S |
p. |
artikel |
554 |
HER2-specific Affibody Molecule [99mTc]Tc-ZHER2:41071: phase I clinical trial
|
Tolmachev, Vladimir |
|
|
76-77 |
S |
p. |
artikel |
555 |
High affinity novel CXCR4 antagonists radiolabelled with copper-67 and gallium-68 for theragnostic applications
|
Palmer, Max |
|
|
76-77 |
S |
p. S59-S60 |
artikel |
556 |
Highly automated solid target-based production of the emerging PET isotope cobalt-55
|
Gé, Lorraine |
|
|
76-77 |
S |
p. S170 |
artikel |
557 |
Highly modifiable cyclopentadienyl scaffolds for the rapid development of 99mTc radioprobes
|
Lengacher, Rapahel |
|
|
76-77 |
S |
p. S90 |
artikel |
558 |
High radiochemical yield and molar activity 52gMn from electroplated chromium
|
Barrett, Kendall |
|
|
76-77 |
S |
p. |
artikel |
559 |
High-sensitivity ICP-MS – an alternative for in vitro and in vivo characterization of future radiometal-based theranostic candidates
|
Wallimann, Rahel |
|
|
76-77 |
S |
p. S42-S43 |
artikel |
560 |
High yield GMP production of [18F]FE-PE2I, a radiotracer for in vivo PET imaging the dopamine transporter
|
Moein, Mohammad Mahdi |
|
|
76-77 |
S |
p. S132-S133 |
artikel |
561 |
High yield lead-203 cyclotron production using a thallium-205 sealed solid target for diagnostic SPECT imaging
|
Nelson, Bryce |
|
|
76-77 |
S |
p. S12 |
artikel |
562 |
[3H]OF-NB1 and [18F]OF-NB1: novel radioligands for the preclinical assessment of GluN1/2B targeting ligands
|
Ahmed, Hazem |
|
|
76-77 |
S |
p. S95-S96 |
artikel |
563 |
Hyaluronic acid as a potential component of radiopharmaceutical with rhenium-188 for radiosynovectomy
|
Malysheva, Anna |
|
|
76-77 |
S |
p. S41 |
artikel |
564 |
Hypoxia targeting lutetium-177 labeled gold nanoparticles for cancer theranostic application
|
Mittal, Sweety |
|
|
76-77 |
S |
p. S162-S163 |
artikel |
565 |
Identification of non-competitive lead peptides for the development of PET tracers targeting PD-L1
|
Badenhorst, Melinda |
|
|
76-77 |
S |
p. |
artikel |
566 |
Identification of (R)-[18F]YH134 as a promising reversible MAGL PET tracer and the impact of peripheral MAGL blockade on its brain uptake
|
Mu, Linjing |
|
|
76-77 |
S |
p. |
artikel |
567 |
Identifying Lymph Node Metastasis in High Grade Serous Ovarian Cancer Mouse Models via ImmunoPET Imaging
|
Mack, Kyeara |
|
|
76-77 |
S |
p. |
artikel |
568 |
Identifying new antigens on osteosarcoma and developing novel antibodies for radioimmunotherapy
|
Prabaharan, Chandra |
|
|
76-77 |
S |
p. S209-S210 |
artikel |
569 |
Identifying Toxicity Mechanisms Associated with f-block Radiometals through Genome-wide Toxicogenomics
|
Pallares, Roger Molto |
|
|
76-77 |
S |
p. |
artikel |
570 |
Imaging acute and chronic stress using 2-[18F]FDG PET
|
Krisch, Maximilian |
|
|
76-77 |
S |
p. |
artikel |
571 |
Imaging characterization of National Cancer Institute patient derived xenograft models
|
Drake, Christopher |
|
|
76-77 |
S |
p. S185-S186 |
artikel |
572 |
Imaging Lung Tumor Metastasis with 89Zr-DFO-Crizanlizumab Targeting P-selectin
|
Majekodunmi, Olufolake |
|
|
76-77 |
S |
p. |
artikel |
573 |
Imaging of AAV-mediated gene transfer in the brain using a novel PET reporter gene tracer
|
Stotz, Sophie |
|
|
76-77 |
S |
p. S106-S107 |
artikel |
574 |
Imaging the Sirtuin 2 (SIRT2) protein - [18F]PF-SIRT, a novel positron emission tomography radioligand candidate
|
Read, Cai |
|
|
76-77 |
S |
p. |
artikel |
575 |
Imidazolium Salt-Mediated Radiofluorosulfurylation to Produce 18F-labeled Aryl Fluorosulfates
|
Kim, Jaegwan |
|
|
76-77 |
S |
p. |
artikel |
576 |
Immune mediated inflammation and perfusion in lungs of Covid-19 patients studied with [11C]GW457427 and [15O]water: a first-in-man pilot study
|
Antoni, Gunnar |
|
|
76-77 |
S |
p. S63 |
artikel |
577 |
ImmunoPET imaging combined with focused ultrasound to study brain pharmacokinetic of 89Zr labeled anti-PD-L1 antibodies in a syngeneic murine model of glioblastoma
|
Chevaleyre, Céline |
|
|
76-77 |
S |
p. S181-S182 |
artikel |
578 |
Implementation and optimisation of scandium-44 and manganese-52 production at King’s College London for preclinical research
|
Nielsen, Karin Michaelsen |
|
|
76-77 |
S |
p. |
artikel |
579 |
Implementation of iMiDEV, a new fully automated microfluidic platform for radiopharmaceutical production
|
Ovdiichuk, Olga |
|
|
76-77 |
S |
p. S60-S61 |
artikel |
580 |
Improved droplet-based method for isotopic exchange labeling of trifluoroborate precursors
|
Lisova, Ksenia |
|
|
76-77 |
S |
p. S64-S65 |
artikel |
581 |
Improved Purification of Cyclotron Produced [68Ga]GaCl3 for the Radiolabeling of Dotatate
|
Wang, Ivan |
|
|
76-77 |
S |
p. |
artikel |
582 |
Improved Synthesis and Automation of 2-(2,6-Difluoro-4-((2-(phenylsulfonamido)ethyl)thio)phenoxy)acetamide ([11C]K2) for Imaging AMPA Receptors
|
Witek, Jason |
|
|
76-77 |
S |
p. |
artikel |
583 |
Improved Synthesis of 3-[18F]Fluoro-p-Hydroxyphenethylguanidine ([18F]3F-PHPG) for Clinical Evaluation of Paraganglioma, Pheochromocytoma and Related Neuroendocrine Tumors
|
Brooks, Allen |
|
|
76-77 |
S |
p. |
artikel |
584 |
Improved synthesis of [18F]FPATPP via Ru-mediated 18F-Fluorination
|
Rajala, Noora |
|
|
76-77 |
S |
p. S135 |
artikel |
585 |
Improvements in separation of antimony-119 from bulk tin target using a novel dibutyl ether resin
|
Grundmane, Aivija |
|
|
76-77 |
S |
p. |
artikel |
586 |
Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-74
|
Toms, Johannes |
|
|
76-77 |
S |
p. |
artikel |
587 |
Improving the quality of Ga radionuclides to achieve high radiolabeling yields
|
Grundler, Pascal |
|
|
76-77 |
S |
p. S45 |
artikel |
588 |
111In/225Ac theranostic pretargeting of nodular colorectal peritoneal carcinomatosis: preclinical SPECT and autoradiography studies
|
Chung, Sebastian |
|
|
76-77 |
S |
p. S50 |
artikel |
589 |
Indigenous preparation, quality control and evaluation of [90Y] Y-glass microspheres for treatment of liver cancer in India
|
Chakraborty, Sudipta |
|
|
76-77 |
S |
p. S180-S181 |
artikel |
590 |
Influence of albumin binders on tumor uptake of [225Ac]Ac-mcp-PSMA radioconjugates
|
Mamat, Constantin |
|
|
76-77 |
S |
p. S29 |
artikel |
591 |
Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody
|
Rauscher, A. |
|
2014 |
76-77 |
S |
p. e66-e74 nvt p. |
artikel |
592 |
Influence of radiolysis on astatine-211 chemistry
|
Ghalei, Mohammad |
|
|
76-77 |
S |
p. S142 |
artikel |
593 |
Influence of short PEG linkers on biodistribution of 225Ac-Macropa-YS5, an immunoconjugate for treating CD46 expressing cancer
|
Bobba, Kondapa |
|
|
76-77 |
S |
p. S53 |
artikel |
594 |
Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis
|
Vizier, Romane |
|
|
76-77 |
S |
p. S120 |
artikel |
595 |
Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis
|
Vizier, Romane |
|
|
76-77 |
S |
p. S97 |
artikel |
596 |
Initial in vitro study of superparamagnetic iron oxide nanoparticles coated with 198AU for targeted radionuclide therapy and magnetic hyperthermia
|
Zuk, Michal |
|
|
76-77 |
S |
p. S87 |
artikel |
597 |
Initial results of clinical phase 0 study on [68Ga]Ga-BOT5035/PET for the assessment of fibrosis activity
|
Velikyan, Irina |
|
|
76-77 |
S |
p. S68-S69 |
artikel |
598 |
111In-labeled-anti-EphA2 antibody for SPECT imaging tracer targeting erythropoietin-producing hepatocellular receptor A2
|
Kimura, Hiroyuki |
|
|
76-77 |
S |
p. |
artikel |
599 |
Inorganic ion molar absorptivity at higher energy UV wavelengths and how it affects high performance liquid chromatography results
|
Arkins, Chase |
|
|
76-77 |
S |
p. |
artikel |
600 |
In search of the HIV reservoir and a cure: translation of a CD30 imaging agent
|
VanBrocklin, Henry |
|
|
76-77 |
S |
p. S52 |
artikel |
601 |
Intermediates en route to [99mTc]Tc-sestamibi: insights from HPLC and HPLC-MS
|
do Mar Machado, Joana |
|
|
76-77 |
S |
p. S36 |
artikel |
602 |
INTERNATIONAL SCIENTIFIC PROGRAM COMMITTEE
|
|
|
|
76-77 |
S |
p. |
artikel |
603 |
Intramolecular Friedel-Crafts acylation of carbon-11 isocyanates enabling radiolabeling of [carbonyl-11C]DPQ
|
Pichler, Verena |
|
|
76-77 |
S |
p. |
artikel |
604 |
INTRODUCTION
|
Cutler, Cathy S. |
|
|
76-77 |
S |
p. S1-S2 |
artikel |
605 |
Introduction of a polyethylene glycol linker enhances uptake of 64Cu-NOTA-conjugated lactam-cyclized alpha-MSH peptide in melanoma
|
Qiao, Zheng |
|
|
76-77 |
S |
p. S70 |
artikel |
606 |
Introduction of terbium-161 into the clinics through its automated purification and the Good Manufacturing Practice compliant production of [161Tb]Tb-DOTA-LM3
|
Favaretto, Chiara |
|
|
76-77 |
S |
p. |
artikel |
607 |
Introduction to this Abstract Supplement
|
|
|
|
76-77 |
S |
p. iii |
artikel |
608 |
Introduction to this Abstract Supplement
|
|
|
|
76-77 |
S |
p. ii |
artikel |
609 |
Investigating different chelators for a pretargeting approach with 203:212Pb- and 64:67Cu-labeled tetrazines
|
Bauer, David |
|
|
76-77 |
S |
p. S28-S29 |
artikel |
610 |
Investigating the chemical scope of protein-ligation using photoactivatable chelates
|
Earley, Daniel |
|
|
76-77 |
S |
p. S114 |
artikel |
611 |
Investigating the stereochemical requirements in the design of 68Ga-radiolabelled fibroblast activation protein inhibitors
|
Flores, Jose Esteban |
|
|
76-77 |
S |
p. S187 |
artikel |
612 |
Investigating the theranostic potential of a novel MUC16-targeted antibody for ovarian cancer
|
Mack, Kyeara |
|
|
76-77 |
S |
p. S58-S59 |
artikel |
613 |
Investigation into metabolic profile of [11C]Me-DPA
|
Thomas, Keller |
|
|
76-77 |
S |
p. |
artikel |
614 |
Investigation of cell surface murine CD68 as a pan-macrophage biomarker by immunoSPECT and optical imaging
|
Roohani, Borna |
|
|
76-77 |
S |
p. |
artikel |
615 |
Investigation of [18F]Regioisomer Formation in the Radiofluorination of Hypervalent Aryl Iodonium Salts and Ylides
|
Zhao, Qunchao |
|
|
76-77 |
S |
p. |
artikel |
616 |
Investigation of 68Ga/177Lu-labeled FAP-based inhibitor for diagnostic and therapeutic applications
|
Imlimthan, Surachet |
|
|
76-77 |
S |
p. S56-S57 |
artikel |
617 |
Investigation of therapeutic effect, associated hypoxia and antioxidant signaling induced by copper-64 in colon carcinoma
|
Niculae, Dana |
|
|
76-77 |
S |
p. |
artikel |
618 |
Investigations of terbium-161 towards prostate cancer therapy using albumin-binding and standard PSMA ligands
|
Müller, Cristina |
|
|
76-77 |
S |
p. S27-S28 |
artikel |
619 |
In vitro and in vivo evaluation of a 89Zr-labeled anti-TIP1 antibody
|
Villas Boas, Cristian Wieczorek |
|
|
76-77 |
S |
p. S37-S38 |
artikel |
620 |
In vitro and in vivo evaluation of [11C]M4K2127 for PET imaging activin receptor-like kinase 2
|
Chasse, Melissa |
|
|
76-77 |
S |
p. |
artikel |
621 |
In vitro and preliminary in vivo assessment of monocarboxylate transporter ligand as potential radiotracer for single photon emission computed tomography (SPECT) imaging of triple-negative breast cancer
|
Schmitt, Sébastien |
|
|
76-77 |
S |
p. S205 |
artikel |
622 |
In-vitro binding assessment of soluble and insoluble tau protein variants with [18F]-AV1451 and [18F]-MK6240
|
Bansal, Aditya |
|
|
76-77 |
S |
p. S99-S100 |
artikel |
623 |
In vitro binding characteristic evaluation of radioconjugates targeting NRP-1 and: or NK1 receptor on glioma cancer model
|
Halik, Pawel |
|
|
76-77 |
S |
p. S53-S54 |
artikel |
624 |
In vitro Characterizations of an S1PR1 Specific Radioligand [3H] CS1P1 in the Central Nervous System
|
Jiang, Hao |
|
|
76-77 |
S |
p. S30 |
artikel |
625 |
In vitro evaluation of [18F]FDG-N3 cell uptake and intracellular SPAAC reactivity using Hoechst-DBCO
|
Kovacs, Luciana |
|
|
76-77 |
S |
p. |
artikel |
626 |
In vitro evaluation of 18F-fluorinated D-methionine and D-tyrosine derivatives as potential radiotracers for PET imaging of bacterial infection
|
Betts, Helen |
|
|
76-77 |
S |
p. S63-S64 |
artikel |
627 |
In vitro evaluation of GPR17 radioligands as potential CNS stem cell imaging agents
|
Kealey, Steven |
|
|
76-77 |
S |
p. S38-S39 |
artikel |
628 |
In Vitro Evaluation of [3H]PI-2620 and Structural Derivative in non-Alzheimer’s Tauopathies
|
Varlow, Cassis |
|
|
76-77 |
S |
p. |
artikel |
629 |
In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor
|
Tawate, Megha |
|
|
76-77 |
S |
p. S213 |
artikel |
630 |
In vivo assessment of TNF-a expression by SPECT/CT antibod imaging using click chemistry in mice models of rheumatoid arthritis
|
Yoo, Min Young |
|
|
76-77 |
S |
p. |
artikel |
631 |
In vivo evaluation and optimization of [89Zr]Zr-DFO-NCS and [89Zr] Zr-(oxinate)4 for cell tracking
|
Friberger, Ida |
|
|
76-77 |
S |
p. |
artikel |
632 |
In vivo evaluation of carbon-11 labeled CRANAD-102 as a potential PET tracer for soluble species of amyloid-β species in the brain
|
Staudt, Markus |
|
|
76-77 |
S |
p. S105 |
artikel |
633 |
In vivo evaluation of carbon-11 labeled 6,7-dimethoxy-1,2,3,4-tetrahydroinsoquinoline derivatives (11C-4-MPTHQ) for potential use as σ2R brain PET tracer
|
Kim, Ho Young |
|
|
76-77 |
S |
p. S40 |
artikel |
634 |
In vivo evaluation of [18F]Fluoroethyl Fucose: a PET tracer for imaging and studying tumor senescence
|
Cotton, Jonathan |
|
|
76-77 |
S |
p. |
artikel |
635 |
In vivo PET imaging of 89Zr-labelled Natural Killer cell trafficking to solid tumour under the influence of a therapeutic antibody
|
Pham, Truc |
|
|
76-77 |
S |
p. |
artikel |
636 |
4-Iodophenyl-[18F]fluorosulfate as a versatile building block for Pd-catalyzed cross-coupling reactions
|
Humpert, Swen |
|
|
76-77 |
S |
p. |
artikel |
637 |
Isoindoline bridged [M(arene)2]+ ansa-[3]arenophanes of rhenium and 99mtechnetium
|
Csucker, Joshua |
|
|
76-77 |
S |
p. S4 |
artikel |
638 |
Isolation of glioblastoma cancer stem cells by sedimentation field flow fractionation for the development of 3D models in supramolecular hydrogels
|
Battu, Serge |
|
|
76-77 |
S |
p. S160 |
artikel |
639 |
Isotopic fluorine-18 radiolabelling of the anti-retroviral drug dolutegravir for pet imaging
|
Caillé, Fabien |
|
|
76-77 |
S |
p. S64 |
artikel |
640 |
131I-urease nanomotors as potential radiotherapeutic agents for bladder cancer
|
Gómez, María |
|
|
76-77 |
S |
p. |
artikel |
641 |
133/135La-labeling of bleomycin and its initial radiopharmacological evaluation
|
Nelson, Bryce |
|
|
76-77 |
S |
p. S59 |
artikel |
642 |
Lanatoside C enhances [225Ac]Ac-DOTA-rituximab induced cell cytotoxicity in lymphoma cells
|
Nagarajan, Vinod |
|
|
76-77 |
S |
p. S31 |
artikel |
643 |
Lanatoside C enhances 131I-rituximab treatment in Raji lymphoma cells
|
Song, Kanghyon |
|
|
76-77 |
S |
p. |
artikel |
644 |
Large scale reliable production of [carboxyl-11C]acetate on the Synthra synthesizer.
|
Solovyev, Dmitry |
|
|
76-77 |
S |
p. |
artikel |
645 |
LC/MS coupled to radioactive detection for the chemical characterization of radiopharmaceuticals: identification of multiple intermediates en route to [99mTc]Tc-sestamibi
|
do Mar Ferreira Machado, Joana |
|
|
76-77 |
S |
p. |
artikel |
646 |
Leveraging an open science approach for PET radiotracer discovery: radiolabelling and preliminary neuroimaging of 11C-labelled activin receptor-like kinase 2 inhibitors
|
Murrell, Emily |
|
|
76-77 |
S |
p. S41 |
artikel |
647 |
Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease.
|
Moreno, Oscar |
|
|
76-77 |
S |
p. |
artikel |
648 |
Long term experience in [11C]UCB-J production in Turku PET Centre
|
Krzyczmonik, Anna |
|
|
76-77 |
S |
p. S126-S127 |
artikel |
649 |
Low-dose targeted alpha therapy induces strong anti-tumor effectiveness in combination with immune checkpoint inhibitors
|
Rodman, Samuel |
|
|
76-77 |
S |
p. |
artikel |
650 |
177Lu-, 225Ac- and 111In-labelled nonadentate bispidine ligands: synthesis, radiolabelling experiments and stability assays
|
Kopp, Ina |
|
|
76-77 |
S |
p. S11 |
artikel |
651 |
177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry
|
Sanders, Vanessa |
|
|
76-77 |
S |
p. S25-S26 |
artikel |
652 |
177LuIII- and 225AcIII-labelled bispidine-TATE conjugates: promising candidates for targeting neuroendocrine tumours
|
Kubeil, Manja |
|
|
76-77 |
S |
p. S68 |
artikel |
653 |
177Lu-labeled Lys-urea-Aad-based PSMA-targeting radiotherapeutic agents with low uptake in mouse kidneys and salivary glands
|
Kuo, Hsiou-Ting |
|
|
76-77 |
S |
p. S32-S33 |
artikel |
654 |
177Lu-labeling of on-resin clicked and cyclized HER2-targeting A9 peptide
|
Sharma, Amit |
|
|
76-77 |
S |
p. S47 |
artikel |
655 |
[177Lu]Lu-DOTA-A9: A peptide probe targeting HER2 receptors
|
Sharma, Amit |
|
|
76-77 |
S |
p. S47 |
artikel |
656 |
[177Lu]Lu-labeled gold nanoparticles as tumor hypoxia targeting platforms
|
Mittal, Sweety |
|
|
76-77 |
S |
p. S85-S86 |
artikel |
657 |
[177Lu]Lu-labeled NaGdF4:Ho-Yb@m-SiO2 upconversion nanophosphors: synthesis and characterization as a potent theranostic probe
|
Chakraborty, Sudipta |
|
|
76-77 |
S |
p. S58-S59 |
artikel |
658 |
[177Lu]Lu3+ labeling of Erlotinib analogues targeting EGFR-expressing cancers
|
Jain, Akanksha |
|
|
76-77 |
S |
p. S196 |
artikel |
659 |
Making samrium-153 available for targeted radionuclide therapy
|
Van de Voorde, Michiel |
|
|
76-77 |
S |
p. S13 |
artikel |
660 |
Management of legacy radioactive waste from [153Sm]Sm-lexidronam radiopharmaceutical
|
Cusnir, Ruslan |
|
|
76-77 |
S |
p. S65 |
artikel |
661 |
Mannose Receptor (CD206) Targeting with Aluminum Fluoride-18 Labeled Mannosylated Dextran
|
Andriana, Putri |
|
|
76-77 |
S |
p. |
artikel |
662 |
Manual labeling, bio-distribution and administration of 177Lu-DOTATE: our long term insight at NORI
|
Bokhari, Ayesha |
|
|
76-77 |
S |
p. S122 |
artikel |
663 |
Mass production of 64, 67Cu using accelerator-based fast neutrons
|
Kawabata, Masako |
|
|
76-77 |
S |
p. |
artikel |
664 |
Measurements of 186Re production cross section induced by deuterons on natW target at ARRONAX facility
|
Guertin, Arnaud |
|
2014 |
76-77 |
S |
p. e16-e18 nvt p. |
artikel |
665 |
Metabolic stability and tumor uptake improvements via an ABD-arm in [99mTc]Tc-DT10: first preclinical experiences in pancreatic cancer models
|
Maina-Nock, Theodosia |
|
|
76-77 |
S |
p. S17 |
artikel |
666 |
Metabolites identification of the selective αvβ3 RGDechi chimeric peptides and their [99mTc][Tc(N)PNP]-derivatives
|
Carpanese, Debora |
|
|
76-77 |
S |
p. S44 |
artikel |
667 |
Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery
|
Graham, Thomas |
|
|
76-77 |
S |
p. S13 |
artikel |
668 |
Method development for centralized clinical production of 177Lu-PNT2002
|
Dornan, Mark |
|
|
76-77 |
S |
p. |
artikel |
669 |
mGluR5 exploration in healthy subject by [18F]FPEB
|
Vercouillie, Johnny |
|
|
76-77 |
S |
p. S109 |
artikel |
670 |
Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursors
|
Zhang, Wei |
|
|
76-77 |
S |
p. S88-S89 |
artikel |
671 |
Mild condition radiolabelling and in vivo stability of nanobody constructs with terbium-161 and terbium-155
|
Cassells, Irwin |
|
|
76-77 |
S |
p. S53-S54 |
artikel |
672 |
Mitochondria-targeted radiocomplexes for cancer theranostics
|
Fernandes, Célia |
|
|
76-77 |
S |
p. S51-S52 |
artikel |
673 |
Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG
|
Schulte, Michael |
|
|
76-77 |
S |
p. S135-S136 |
artikel |
674 |
Modification of the synthesis of 18F-labeled FC-119S for our automated synthesizer
|
Kato, Koichi |
|
|
76-77 |
S |
p. |
artikel |
675 |
Molecular imaging and radiopharmaceutical therapy of Multiple Myeloma targeting CD46 using 89Zr and 225Ac-YS5
|
Wadhwa, Anju |
|
|
76-77 |
S |
p. |
artikel |
676 |
Molecular imaging for systemic treatment decisions in patients with cancer
|
de Vries, Elisabeth GE |
|
|
76-77 |
S |
p. S1 |
artikel |
677 |
Molecular imaging of alcoholic liver disease with phosphodiesterase (PDE) 4B targeted [18F]PF-06445974 and positron emission tomography
|
Shao, Tuo |
|
|
76-77 |
S |
p. S18 |
artikel |
678 |
Molecular imaging of cerebral dysfunction following liver failure with cannabinoid receptor type I targeted [18F]MK-9470 and positron emission tomography
|
Shao, Tuo |
|
|
76-77 |
S |
p. S53-S54 |
artikel |
679 |
Molecular imaging of LPS induced neuroinflammation with P2x7 targeted [18F]JNJ-64413739 by positron emission tomography
|
Chen, Jiahui |
|
|
76-77 |
S |
p. S92-S93 |
artikel |
680 |
Molecular imaging of murine liver fibrosis with sphingosine-1-phosphate receptor 1 targeted PET ligand
|
Shao, Tuo |
|
|
76-77 |
S |
p. S55-S56 |
artikel |
681 |
Molecular imaging of Poly (ADP-ribose) polymerase for nnalcoholic steatohepatitis detection in preclinical models
|
Jeppesen, Troels |
|
|
76-77 |
S |
p. S67-S68 |
artikel |
682 |
Molecular imaging of PSA using DARPin scaffolds
|
Gut, Melanie |
|
|
76-77 |
S |
p. S190-S191 |
artikel |
683 |
Molecular Radiation Resistance Signature Induced by Alpha Emitters in Metastatic Castration-resistant Prostate Cancer: Early Clinical Outcome Prediction
|
Amghar, Mariam |
|
|
76-77 |
S |
p. |
artikel |
684 |
99mTc-labeled PSMA SPECT CT: a cost effective alternate of PET CT in diagnostic algorithm of prostate cancer
|
Mir, Kahkashan |
|
|
76-77 |
S |
p. S204 |
artikel |
685 |
99mTc/Re tricarbonyl biguanide complexes for cancer theranostics
|
Xiong, Chiyi |
|
|
76-77 |
S |
p. S58 |
artikel |
686 |
[99mTc]Tc-HYNIC-EcgDf21: a defensin short analog with potential application in infection foci imaging
|
Gretter, Mariella Terán |
|
|
76-77 |
S |
p. S63 |
artikel |
687 |
[99mTc]Tc-(η6-pharm)2]+ synthesis with direct labelling of pharmaceuticals in water
|
Battistin, Federica |
|
|
76-77 |
S |
p. S3 |
artikel |
688 |
[99mTc]Tc-PSMA-T4 a potential radiofarmaceutical for SPECT/CT imaging of metastatic prostate cancer
|
Wojdowska, Wioletta |
|
|
76-77 |
S |
p. |
artikel |
689 |
Multimodal radiobioconjugate - Trastuzumab-PEG-[198Au]AuNPs-PEG-DOX for targeted radionuclide therapy of HER2-positive cancers
|
Żelechowska-Matysiak, Kinga |
|
|
76-77 |
S |
p. S86 |
artikel |
690 |
Nanoparticles as a Radionuclide Generator System for 225Ac/213Bi
|
Diehl, George |
|
|
76-77 |
S |
p. |
artikel |
691 |
Nanoscale microfluidic reactions: towards near-stoichiometric carbon-11 radiolabelling for PET
|
Edgar, Fraser |
|
|
76-77 |
S |
p. S69-S70 |
artikel |
692 |
Nanosized crystalline vehicle for targeted radionuclide therapy
|
Lemaître, Tom |
|
|
76-77 |
S |
p. |
artikel |
693 |
Neuroimaging of p38 MAPK with [11C]SCIO-469 Enabled by Inhibition of P-glycoprotein
|
Chasse, Melissa |
|
|
76-77 |
S |
p. |
artikel |
694 |
New bicyclic somatostatin receptor agonists for imaging and therapy of neuroendocrine neoplasia
|
Franchi, Sara |
|
|
76-77 |
S |
p. S66-S67 |
artikel |
695 |
New bifunctional linchpin for tandem peptide cyclization/ radiometal incorporation
|
Yuen, Richard |
|
|
76-77 |
S |
p. S120 |
artikel |
696 |
New CD8 imaging agents to evaluate T-cell infiltration in tumors and predict response to immunotherapy
|
Vivier, Delphine |
|
|
76-77 |
S |
p. S218-S219 |
artikel |
697 |
New extractant-impregnated iTLC-SG paper facilitates improved TLC analysis for Cu radiolabelled peptides
|
Svedjehed, Johan |
|
|
76-77 |
S |
p. S72 |
artikel |
698 |
New H2dedpa derivatives designed for [67/68Ga]Ga3+ and [64Cu]Cu2+ radiopharmaceutical applications
|
de Guadalupe Jaraquemada-Pelaez, Maria |
|
|
76-77 |
S |
p. S149 |
artikel |
699 |
NEw materials for conducting radiosynthesis of 18F-compounds
|
Maindron, Nicolas |
|
|
76-77 |
S |
p. S129-S130 |
artikel |
700 |
New phase transfer agents for fluorine 18 radiolabelling
|
Pelletier, Rémi |
|
|
76-77 |
S |
p. S16-S17 |
artikel |
701 |
New prospects for 89Zr-immuno-PET in brain applications: Alpha-synucleinopathies
|
Wuensche, Thomas |
|
|
76-77 |
S |
p. |
artikel |
702 |
New way to refine direct aromatic 18F-labeling of tetrazines
|
Andersen, Ida |
|
|
76-77 |
S |
p. S76 |
artikel |
703 |
Next generation copper complexes for efficient production of radiolabeled aromatics
|
Hoffmann, Chris |
|
|
76-77 |
S |
p. |
artikel |
704 |
Next Generation of Radiopharmaceuticals via Engineering Antibody Derivatives
|
Castilla, Susana Granados |
|
|
76-77 |
S |
p. |
artikel |
705 |
Next generation therapeutic radiopharmaceuticals targeting cholecystokinin-2 receptor positive cancers
|
Corlett, Alicia |
|
|
76-77 |
S |
p. S16 |
artikel |
706 |
Non-invasive assessment of fibrogenesis by PET imaging using a [Al18F]RESCA-Affibody molecule targeting PDGFRβ
|
Wegrzyniak, Olivia |
|
|
76-77 |
S |
p. |
artikel |
707 |
Non-invasive imaging of neutrophils in acute sepsis
|
Wilske, Frida |
|
|
76-77 |
S |
p. |
artikel |
708 |
Noninvasive imaging of STING expression in tumor microenvironment using radioiodinated small molecule
|
Fang, Jianyang |
|
|
76-77 |
S |
p. S52 |
artikel |
709 |
Novel bifunctional [16]aneS4-derived chelators for soft radiometals
|
Straathof, Natan |
|
|
76-77 |
S |
p. S157 |
artikel |
710 |
Novel boron-containing amino acid analogs for tumor positron tomography and boron neutron capture therapy
|
Chen, Junyi |
|
|
76-77 |
S |
p. S181 |
artikel |
711 |
Novel FAPI tracers with albumin-binding properties for cancer imaging and therapy
|
Meng, Lingxin |
|
|
76-77 |
S |
p. S59 |
artikel |
712 |
Novel folate radioconjugates: optimization of functional units to improve the tissue distribution profile
|
Becker, Anna |
|
|
76-77 |
S |
p. S11-S12 |
artikel |
713 |
Novel 68Ga-labelled nanobody for imaging of platelet-derived growth factor receptor beta
|
Velikyan, Irina |
|
|
76-77 |
S |
p. |
artikel |
714 |
Novel [68Ga/177Lu]Ga/Lu-AAZTA-PSMA-093 as PSMA targeting agent for diagnosis and radiotherapy
|
Liu, Tianqing |
|
|
76-77 |
S |
p. |
artikel |
715 |
Novel [124I]ATRi VE-821 analogue PET tracer in mouse models for prostate cancer
|
Artschwager, Raik |
|
|
76-77 |
S |
p. S177 |
artikel |
716 |
Novel 99mTc labelled proline isocyanide derivatives as potential tumour imaging agents
|
Ruan, Qing |
|
|
76-77 |
S |
p. S43-S44 |
artikel |
717 |
Novel pyrazolethiazole derivatives as a promising new class of ligands for alpha-synuclein fibrils and potential PET tracers for the detection of α-synucleinopathies
|
Bonanno, Federica |
|
|
76-77 |
S |
p. |
artikel |
718 |
Novel pyrazolethiazole derivatives as new high affinity and selective ligands for alpha-synuclein fibrils as potential PET tracers for Parkinson’s disease
|
Bonanno, Federica |
|
|
76-77 |
S |
p. S90-S91 |
artikel |
719 |
Novel Radiofluorination via Electrophilic Activation of Alkyl Phosphates/Phosphonate
|
Zhang, Kaiqiang |
|
|
76-77 |
S |
p. |
artikel |
720 |
Novel Universal Agent for Cutaneous Radioactive Decontamination
|
Craig, Austin |
|
|
76-77 |
S |
p. |
artikel |
721 |
Occupancy of Glucagon Like Peptide-1 receptor by Tirzepatide and SAR441255 measured with [68Ga]Ga-DO3A-exendin-4/PET in vivo.
|
Khalil, Amina |
|
|
76-77 |
S |
p. |
artikel |
722 |
O-[18F]fluoroalkylation of phenol derivatives with [18F] epifluorohydrin in the presence of t-Bu-P4 base
|
Fujinaga, Masayuki |
|
|
76-77 |
S |
p. |
artikel |
723 |
One batch multiple clinical doses production of [18F]FET with an home-built automated multipurpose [18F]-radiosynthesis module
|
Zheng, Qi-Huang |
|
|
76-77 |
S |
p. S139-S140 |
artikel |
724 |
‘One-fits-both’: searching a ligand for the chelation of theranostic mercury and silver radioisotopes
|
Tosato, Marianna |
|
|
76-77 |
S |
p. S11-S12 |
artikel |
725 |
One-step automated radiosynthesis of N-succinimidyl-4-[18F]Fluorobenzoate ([18F]SFB)
|
Nagachinta, Surasa |
|
|
76-77 |
S |
p. S117 |
artikel |
726 |
On the regiochemistry of the synthesis of 18F-labelled difluoroarenes via the copper mediated substitution of tin derivatives
|
Stouse, Adrien |
|
|
76-77 |
S |
p. S36-S37 |
artikel |
727 |
Open-shell nanosensitizers for glutathione-responsive sonodynamic therapy of breast cancer
|
Ni, Dalong |
|
|
76-77 |
S |
p. S26-S27 |
artikel |
728 |
Operation of a thorium-229/actinium-225 generator at Canadian Nuclear Laboratories
|
Perron, Randy |
|
|
76-77 |
S |
p. |
artikel |
729 |
Optical Imaging with a biological vector for diagnosis of oncologic diseases
|
Thakur, Mathew |
|
|
76-77 |
S |
p. |
artikel |
730 |
Optimal ‘hardness’ of non-macrocyclic chelators for [203Pb]Pb2+ radiopharmaceutical applications
|
Ingham, Aidan |
|
|
76-77 |
S |
p. S25 |
artikel |
731 |
Optimisation of the radiosynthesis of [18F]FDG on MX cassette: application to the dual batch process on NEPTIS® platform
|
Maindron, Nicolas |
|
|
76-77 |
S |
p. S128-S129 |
artikel |
732 |
Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with 44m/44Sc and experimental evidence of the feasibility of an in vivo PET generator
|
Huclier-Markai, S. |
|
2014 |
76-77 |
S |
p. e36-e43 nvt p. |
artikel |
733 |
Optimization of reaction volumes and reagent amounts for the preparation of various 18F-radiolabelled radiotracers
|
Maindron, Nicolas |
|
|
76-77 |
S |
p. S130 |
artikel |
734 |
Optimization of the automated radiosynthesis of an 18F-labeled tetrahydroquinoline derivative for brain HDAC6 imaging
|
Tago, Tetsuro |
|
|
76-77 |
S |
p. |
artikel |
735 |
Optimization of the routine production of the ketone body tracer (R)-[11C]3-hydroxybutyric acid
|
Nielsen, Erik |
|
|
76-77 |
S |
p. S23-S24 |
artikel |
736 |
Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [68Ga]Ga-ABY-025 tracer
|
Jussing, Emma |
|
|
76-77 |
S |
p. |
artikel |
737 |
Optimized pretargeting of [89Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer
|
Le Roux, Alexandre |
|
|
76-77 |
S |
p. S3-S4 |
artikel |
738 |
Optimized QMA-elution enables direct aliphatic 18F-fluorination of highly reactive tetrazines for pretargeted imaging
|
Bratteby, Klas |
|
|
76-77 |
S |
p. S79-S80 |
artikel |
739 |
Optimized quality control analysis for GMP production of the clinical 18F-labelled NET tracer [18F]SiTATE
|
Kerminen, Edla |
|
|
76-77 |
S |
p. |
artikel |
740 |
Optimized Radiosynthesis of Racemic 2-[18F]Fluoropropionic Acid for PET Imaging of Incipient Heart Failure
|
Singh, Pradeep |
|
|
76-77 |
S |
p. |
artikel |
741 |
Optimized synthesis of tri(hydroxypyridinone)-tetrazine and 68Ga-radiolabeling for bioorthogonal chemistry
|
Centanni, Alessia |
|
|
76-77 |
S |
p. S50-S51 |
artikel |
742 |
Optimized synthesis of tris(hydroxypyridinone)-tetrazine and 68Ga radiolabeling for bioorthogonal chemistry
|
Centanni, Alessia |
|
|
76-77 |
S |
p. S148-S149 |
artikel |
743 |
Optimizing 203Pb cyclotron production and availability: The ideal SPECT imaging theranostic partner for 212Pb targeted alpha therapy
|
Nelson, Bryce |
|
|
76-77 |
S |
p. |
artikel |
744 |
Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synuclein
|
Bratteby, Klas |
|
|
76-77 |
S |
p. S87-S88 |
artikel |
745 |
Organometallic cancer theranostics: incorporation of Re and 99mTc into the small molecule kinase inhibitor Opaganib®
|
Lengacher, Raphael |
|
|
76-77 |
S |
p. S55-S56 |
artikel |
746 |
Organotin derivatives as versatile precursors for the radioiodination and radiofluorination of 1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid (TIC(OH)) analogues
|
Maisonial-Besset, Aurélie |
|
|
76-77 |
S |
p. S17 |
artikel |
747 |
Original 18F-thiol prosthetic group for labeling of dehydroalanine-containing biologics
|
Richard, Mylène |
|
|
76-77 |
S |
p. S75 |
artikel |
748 |
Our experiences working with the development module Neptis x Seed
|
Ohlsson, Tomas |
|
|
76-77 |
S |
p. |
artikel |
749 |
[15O]Water – a timeless challenge under GMP
|
Ross, Tobias |
|
|
76-77 |
S |
p. |
artikel |
750 |
Palladium-mediated synthesis of 11C-labelled acyl amidines and their cyclization to 11C-labelled 1,2,4-oxadiazoles from aryl halides and amidines
|
Roslin, Sara |
|
|
76-77 |
S |
p. |
artikel |
751 |
PAM and FUS-assisted local AAV gene delivery into the brain of Alzheimer’s disease murine models assessed by quantitative PET reporter gene
|
Ajenjo, Javier |
|
|
76-77 |
S |
p. |
artikel |
752 |
3p-C-NETA-TATE: a versatile somatostatin analogue for Al18F-labeled and therapeutic SSTR2 targeting radiopharmaceuticals
|
Ahenkorah, Stephen |
|
|
76-77 |
S |
p. S10-S11 |
artikel |
753 |
PEGylated liposome encapsulating nido-carborane: boron neutron capture therapy (BNCT) and in vivo trafficking study in animal models
|
Kim, Kyungwon |
|
|
76-77 |
S |
p. S15 |
artikel |
754 |
PEGylation modulation of peptides promotes PET detection of cancers
|
Hu, Kuan |
|
|
76-77 |
S |
p. S88-S89 |
artikel |
755 |
Peptide turn mimics formed by the coordination of Tc:Re-tricarbonyl
|
Oza, Dhvani |
|
|
76-77 |
S |
p. S5 |
artikel |
756 |
Perfluoroaryl azide staudinger reaction combined with sulfur [18F]Fluoride exchange click chemistry for live cell radiolabeling
|
Biti, Anisa |
|
|
76-77 |
S |
p. S78 |
artikel |
757 |
Performance assessment of quantitative preclinical SPECT imaging with 155Tb and 161Tb
|
Koniar, Helena |
|
|
76-77 |
S |
p. |
artikel |
758 |
Performance evaluation of the IRIS XL-220 PET/CT system, a new camera dedicated to non-human primates
|
Boisson, Frédéric |
|
|
76-77 |
S |
p. S173 |
artikel |
759 |
PET/CT Imaging of avb6 Integrin to Monitor Radiation-Induced Pulmonary Fibrosis
|
Villas Boas, Cristian Wieczorek |
|
|
76-77 |
S |
p. |
artikel |
760 |
PET/CT Imaging Reveals Enhanced Spleen Uptake After Humanization of an Annexin A1 Targeting Antibody
|
Houson, Hailey |
|
|
76-77 |
S |
p. |
artikel |
761 |
PET imaging and biological uptake of toxic diesel particulate matter in mice via different routes of exposure
|
Park, Jung Eun |
|
|
76-77 |
S |
p. |
artikel |
762 |
PET Imaging of [68Ga]Ga-NOTA-insulin in Alzheimer’s disease mouse model
|
Pandey, Mukesh |
|
|
76-77 |
S |
p. |
artikel |
763 |
PET imaging of lung inflammation in pig by neutrophil elastase inhibitor [11C]GW457427
|
Eriksson, Olof |
|
|
76-77 |
S |
p. S65 |
artikel |
764 |
PET imaging of neurotensin receptor-positive tumors with 68Ga-labeled antagonists: “the chelate makes again the difference”
|
Renard, Emma |
|
|
76-77 |
S |
p. S6-S7 |
artikel |
765 |
PET Imaging of Neurotensin Targeting Peptide NOTA-NT-20.3 Using Cobalt-55, Copper-64 and Gallium-68
|
Houson, Hailey |
|
|
76-77 |
S |
p. |
artikel |
766 |
PET imaging of PD-L1 expression in brain tumours
|
Sharma, Gitanjali |
|
|
76-77 |
S |
p. |
artikel |
767 |
PET imaging of PD-L1 overexpressing tumors with a 68Ga labeled D-dodecapeptide
|
Hu, Kuan |
|
|
76-77 |
S |
p. S2 |
artikel |
768 |
Pharmacokinetic, dosimetry and antitumor efficacy of 64Cu/NOTA-terpyridine platinum, a potential radio-chemo-theranostic agent
|
Khosravifarsani, Meysam |
|
|
76-77 |
S |
p. S57 |
artikel |
769 |
Pharmacokinetic preclinical evaluation of radioligation strategies impact on antibody fragment targeting PD-L1
|
Truillet, Charles |
|
|
76-77 |
S |
p. S118-S119 |
artikel |
770 |
Pharmacokinetics, Dosimetry and Therapeutic efficacy of [225Ac] Ac-DOTA-TDA-Lipiodol® in a murine cancer model: The importance of considering the actinium-225 in vivo generated decay daughters for accurate treatment dosing
|
Josefsson, Anders |
|
|
76-77 |
S |
p. |
artikel |
771 |
Phase I trial for SPECT imaging of GRPR expression in malignant tumors using [99mTc]Tc-maSSS-PEG2-RM26 prepared using one-pot labeling kit
|
Orlova, Anna |
|
|
76-77 |
S |
p. |
artikel |
772 |
Photoaffinity labeling for the site-specific bioconjugation of 89Zr-labeled radioimmunoconjugates
|
Delaney, Samantha |
|
|
76-77 |
S |
p. S17-S18 |
artikel |
773 |
PhotoDynamicTherapy by Cerenkov luminescence induct by Gallium-68 on AGuIX@Terbium-porphyrin ultrasmall nanoparticle
|
Collet, Charlotte |
|
|
76-77 |
S |
p. S161 |
artikel |
774 |
Photoredox-assisted 18F-radiodeoxyfluorination of diaryl ethers favors the more electron-rich aryl group
|
Jiang, Meijuan |
|
|
76-77 |
S |
p. |
artikel |
775 |
Polyacrylamide gel electrophoresis based method for investigation of metabolic stability of [68Ga]Ga-BOT5035 in vitro and in vivo
|
Velikyan, Irina |
|
|
76-77 |
S |
p. |
artikel |
776 |
Practical considerations on the production of copper radioisotopes from enriched liquid targets: a five years’ experience
|
Fonseca, Alexandra |
|
|
76-77 |
S |
p. S44-S45 |
artikel |
777 |
Preclinical assessment of nanoparticles conjugated with 64Cu-DOTA-PEG-BBN targeting gastrin-releasing peptide receptors
|
Niculae, Dana |
|
|
76-77 |
S |
p. S14-S15 |
artikel |
778 |
Preclinical characterization of [18F]FB-labeled single-domain antibodies for PET imaging of FAP-α or Folate-α overexpression in cancer
|
Dierick, Herlinde |
|
|
76-77 |
S |
p. |
artikel |
779 |
Preclinical development of CD133 targeted immunoPET probes
|
Wyszatko, Kevin |
|
|
76-77 |
S |
p. S19-S20 |
artikel |
780 |
Preclinical development of [89Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas
|
Alvarez, Natalia Herrero |
|
|
76-77 |
S |
p. S192-S193 |
artikel |
781 |
Preclinical evaluation of antisense-oligonucleotide (ASO) brain distribution using PET and SPECT imaging post intrathecal injection
|
Rafidi, Hanine |
|
|
76-77 |
S |
p. |
artikel |
782 |
Preclinical evaluation of ePSMA-DM1: a PSMA-targeting theranostic small molecule drug conjugate
|
Seimbille, Yann |
|
|
76-77 |
S |
p. |
artikel |
783 |
Preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter
|
Vercouillie, Johnny |
|
|
76-77 |
S |
p. S110 |
artikel |
784 |
Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation
|
Holzleitner, Nadine |
|
|
76-77 |
S |
p. |
artikel |
785 |
Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide
|
El Fakiri, Mohamed |
|
|
76-77 |
S |
p. |
artikel |
786 |
Preclinical evaluation of GRPR-antagonists based on a highly stable variant for imaging of prostate cancer
|
Kanellopoulos, Panagiotis |
|
|
76-77 |
S |
p. |
artikel |
787 |
Preclinical evaluation of [111In]In-labeled GRPR-targeting DB15 mimics for potential theranostic use in prostate cancer
|
Kanellopoulos, Panagiotis |
|
|
76-77 |
S |
p. |
artikel |
788 |
Pre-clinical evaluation of lead-203 as an imaging surrogate for lead-212 radiopharmaceuticals
|
Cagle, Brianna |
|
|
76-77 |
S |
p. S22-S23 |
artikel |
789 |
Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors
|
Wharton, Luke |
|
|
76-77 |
S |
p. |
artikel |
790 |
Preclinical evaluation of [89Zr]Zr-DFO*-sacituzumab, a PET tracer for imaging of whole body TROP-2 expression as a potential selection tool for treatment with TROP-2 antibody drug conjugates (ADC)
|
Bratteby, Klas |
|
|
76-77 |
S |
p. |
artikel |
791 |
Preclinical evaluation of [89Zr]Zr-ramucirumab: the monoclonal antibody for imaging of VEGFR2 positive tumors
|
Novy, Zbynek |
|
|
76-77 |
S |
p. S56-S57 |
artikel |
792 |
Preclinical PET imaging of GSK-3 in pancreatic cancer
|
Boyle, Amanda |
|
|
76-77 |
S |
p. S19 |
artikel |
793 |
Preclinical validation of [18F]-FB-(Anti Human PD-L1) nanobody for PET imaging
|
Dierick, Herlinde |
|
|
76-77 |
S |
p. S141 |
artikel |
794 |
Preface of the Workshop on Innovative Personalized Radioimmunotherapy (WIPR 2013)
|
Huclier, Sandrine |
|
2014 |
76-77 |
S |
p. e1-e6 nvt p. |
artikel |
795 |
Preliminary evaluation of a novel carbon-11 labeled brain-penetrant EGFR-TKI radiotracer for brain cancer imaging
|
Guttormsen, Yngve |
|
|
76-77 |
S |
p. S42-S43 |
artikel |
796 |
Preliminary evaluation of 124I labeled virus receptor binding domain
|
Li, Dan |
|
|
76-77 |
S |
p. S50-S51 |
artikel |
797 |
Preparation and cGMP-compliant production of the bombesin analogue [68Ga]Ga-NOTA-RM26 for first-in-human clinical study of gastrin-releasing peptide receptor expression in prostate cancer
|
Jussing, Emma |
|
|
76-77 |
S |
p. S197-S198 |
artikel |
798 |
Preparation and characterization and radiolabelling of multivalent ligands towards positron emission tomography imaging of oligomeric forms of misfolded proteins involved in neurodegenerative diseases
|
Thompson, Stephen |
|
|
76-77 |
S |
p. S107-S108 |
artikel |
799 |
Preparation and evaluation of an ADAM8-targeted 111In-labeled antibody for the detection of early pancreatic cancer
|
Fuchigami, Takeshi |
|
|
76-77 |
S |
p. |
artikel |
800 |
Preparation and multimodality imaging study of 64Cu labeled organic nanoparticles targeting fibroblasts activation protein (FAP) in U87MG model
|
Wen, Li |
|
|
76-77 |
S |
p. S164-S165 |
artikel |
801 |
Preparation and preclinical evaluation of novel 18F-labeled FAP ligands
|
Hoffmann, Chris |
|
|
76-77 |
S |
p. |
artikel |
802 |
Preparation of a 18F-labeled COX-2 inhibitor via [18F]SuFEx reaction
|
Craig, Austin |
|
|
76-77 |
S |
p. S80 |
artikel |
803 |
Preparation of a representative non-radioactive sterility sample during the preparation of a long-lived radiopharmaceutical
|
Stuijt, Jeffrey |
|
|
76-77 |
S |
p. |
artikel |
804 |
Preparation of 211At-labeled aromatic compounds from thioarylprecursors
|
Maingueneau, Clémence |
|
|
76-77 |
S |
p. S43-S44 |
artikel |
805 |
Preparation of electrodeposited UO2 target for fission-99Mo production
|
Shen, Yijia |
|
|
76-77 |
S |
p. S103-S104 |
artikel |
806 |
Preparation of 5-[18F],7-difluoro- and 5,7-[18F]difluorotryptophans
|
Kolks, Niklas |
|
|
76-77 |
S |
p. S35 |
artikel |
807 |
Preparation of Infective Endocarditis Models and PET Imaging Studies Using [18F]FDG and Other Radiotracers
|
Lim, Jeong Eun |
|
|
76-77 |
S |
p. |
artikel |
808 |
Preparation of radiofluorinated tyrosine derivatives via 18F-SuFEx chemistry and their in vivo evaluation
|
Walter, Nils |
|
|
76-77 |
S |
p. S76 |
artikel |
809 |
Preparation of radiolabeled sulfamoyl fluorides by SuFEx 18F/19F isotopic exchange and assessment of their in vivo stability
|
Hoffmann, Chris |
|
|
76-77 |
S |
p. |
artikel |
810 |
Preparation of titanium complexes for in vivo PET imaging
|
Strecker, Jonas |
|
|
76-77 |
S |
p. S8-S9 |
artikel |
811 |
Preparing a 18F-labeled modification of a PD-L1 inhibitor via [18F] SuFEx reaction
|
Craig, Austin |
|
|
76-77 |
S |
p. S80-S81 |
artikel |
812 |
Preparing Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist [18F]Ubrogepant to Enable Biodistribution Studies in Non-Human Primate
|
Fan, Kuo-Hsien |
|
|
76-77 |
S |
p. |
artikel |
813 |
Pressed chromium/sodium fluoride target for cyclotron production of manganese-52
|
Nielsen, Karin Michaelsen |
|
|
76-77 |
S |
p. S102-S103 |
artikel |
814 |
Pretargeted Alpha Therapy of Disseminated Cancer - Combining Click Chemistry and Astatine-211
|
Timperanza, Chiara |
|
|
76-77 |
S |
p. |
artikel |
815 |
Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids
|
Auchynnikava, Tatsiana |
|
|
76-77 |
S |
p. |
artikel |
816 |
Process validation of Ga-68 labelled FAPI-46 at HUS Diagnostic Center
|
Koivula, Teija |
|
|
76-77 |
S |
p. S143-S144 |
artikel |
817 |
Production and application of the 203Pb/212Pb theranostic pair at TRIUMF
|
McNeil, Brooke |
|
|
76-77 |
S |
p. S95-S96 |
artikel |
818 |
Production and characterization of high purity radioscandium isotopes, 43,47Sc, of clinical interest from proton bombardment on enriched [46,50Ti]TiO2 targets
|
Cingoranelli, Shelbie |
|
|
76-77 |
S |
p. S49-S50 |
artikel |
819 |
Production and purification of the Auger emitters Lanthanum-135 and Erbium-165
|
Pedersen, Kristina |
|
|
76-77 |
S |
p. |
artikel |
820 |
Production and radiochemical separation of terbium-155 from enriched gadolinium target material and its preliminary application in SPECT imaging
|
Favaretto, Chiara |
|
|
76-77 |
S |
p. S50-S51 |
artikel |
821 |
Production of clinical amounts GMP compliant zirconium-89 from cyclotron liquid targets: towards global availability of 89Zr-based radiopharmaceuticals
|
Silva, Magda |
|
|
76-77 |
S |
p. |
artikel |
822 |
Production of emerging theranostic radionuclides at TRIUMF
|
Radchenko, Valery |
|
|
76-77 |
S |
p. S172 |
artikel |
823 |
Production of [18F]fluoromannitol facilitated by solid phase flow chemistry toward PET Imaging of bacterial Infections
|
Jouad, Kamal |
|
|
76-77 |
S |
p. |
artikel |
824 |
Production of high-specific-activity erbium-169, ytterbium-175 and thulium-167
|
Talip, Zeynep |
|
|
76-77 |
S |
p. S13-S14 |
artikel |
825 |
Production of 117mSn using Sb alloy targetry
|
Baumeister, Jakob |
|
|
76-77 |
S |
p. S23-S24 |
artikel |
826 |
Production of PET Radiopharmaceutical for Cholinergic Imaging
|
Latter, Melissa |
|
|
76-77 |
S |
p. |
artikel |
827 |
Production of Strontium-85 via deuteron-induced nuclear reactions on natural rubidium
|
Tanzey, Sean |
|
|
76-77 |
S |
p. S22 |
artikel |
828 |
Production of 89Zr from cyclotron using yttrium foil: a new target design
|
Pandey, Mukesh |
|
|
76-77 |
S |
p. S103 |
artikel |
829 |
Promising potential 68Ga-labeled small-molecular tracers for immune checkpoint ligand PD-L1 expression in tumor
|
Lu, Jie |
|
|
76-77 |
S |
p. S199 |
artikel |
830 |
Proof-of-concept optimization of copper-mediated radiosynthesis of [18F]FBnTP using a novel automated robotic high-throughput droplet radiochemistry system
|
Jones, Jason |
|
|
76-77 |
S |
p. |
artikel |
831 |
Proof of principle: [18F]AlF radiolabelling using a droplet microreactor
|
Lu, Yingqing |
|
|
76-77 |
S |
p. |
artikel |
832 |
Protein 18F radiolabelling by Snap-Tag: synthesis and radiofluorination of O6-benzylguanine derivatives
|
Ariztia, Julen |
|
|
76-77 |
S |
p. S77 |
artikel |
833 |
Quality assessment of cyclotron-produced 67Cu
|
Brühlmann, Santiago |
|
|
76-77 |
S |
p. S42 |
artikel |
834 |
Quality control of 99mTc-radiopharmaceuticals: assessing our clinical practice
|
do Mar Ferreira Machado, Joana |
|
|
76-77 |
S |
p. |
artikel |
835 |
Quantification of radiotracer accumulation in a dynamic column-based 3D cell culture
|
Pichler, Verena |
|
|
76-77 |
S |
p. S14 |
artikel |
836 |
Quantitation of a CB1R tracer [18F]FPATPP with radioLC/MS/MS
|
Lahdenpohja, Salla |
|
|
76-77 |
S |
p. S174 |
artikel |
837 |
Quantitative Evaluation of a Novel PET Radioligand for the Monoacylglycerol Lipase (MAGL) in Non-Human Primates
|
Gu, Jiwei |
|
|
76-77 |
S |
p. |
artikel |
838 |
Quick determination of 90SR/90Y for application in nuclear medicine by counting gross-beta activity
|
Tuan, Hoang |
|
|
76-77 |
S |
p. S172 |
artikel |
839 |
Radiation-induced DNA Damage and Repair in Targeted Radionuclide Therapies in Comparison to External Beam Radiation
|
Winter, Ruth |
|
|
76-77 |
S |
p. |
artikel |
840 |
Radioactive Isotopes for Cancer Radiotherapy
|
Hoehr, Cornelia |
|
|
76-77 |
S |
p. S2 |
artikel |
841 |
Radiobioconjugates of 193m,195mPt nanoparticles for combined “chemo-Auger electron” therapy of hepatocellular carcinoma (HCC) and HER2+ breast and ovarian cancers
|
Wawrowicz, Kamil |
|
|
76-77 |
S |
p. S48 |
artikel |
842 |
Radiochemical aspects of synthesis and analysis of [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T single-dose preparations
|
Larenkov, Anton |
|
|
76-77 |
S |
p. S152 |
artikel |
843 |
Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3
|
Tawate, Megha |
|
|
76-77 |
S |
p. S146 |
artikel |
844 |
Radiochemical synthesis and automation of an 18F-radiolabelled oligonucleotide for PET imaging of miRNA-223 in relation to neuroinflammation
|
Zientek, Simon |
|
|
76-77 |
S |
p. S113-S114 |
artikel |
845 |
Radiochemical synthesis of [18F]Fluoroanilines via flow reduction
|
Wilde, Justin |
|
|
76-77 |
S |
p. S139 |
artikel |
846 |
Radiofluorination of Ruppert-Prakash reagent (Me3SiC[18F]F3) for syntheses of 18F-trifluoromethylated compounds
|
Pees, Anna |
|
|
76-77 |
S |
p. S23 |
artikel |
847 |
Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism
|
Wright, Jay |
|
|
76-77 |
S |
p. |
artikel |
848 |
Radioiodinated and astatinated NHC rhodium complexes: Synthesis
|
Rajerison, Holisoa |
|
2014 |
76-77 |
S |
p. e23-e29 nvt p. |
artikel |
849 |
Radioiodination of galacto-bombesin using a residualizing prosthetic agent for imaging of gastrin-releasing peptide receptor
|
Lim, Hwisoo |
|
|
76-77 |
S |
p. |
artikel |
850 |
Radioiodination of prosthetic groups for disulphide rebridging
|
Krzyczmonik, Anna |
|
|
76-77 |
S |
p. |
artikel |
851 |
Radioisotope-loaded microbubbles for cancer imaging and therapy
|
Gower-Fry, Kaley |
|
|
76-77 |
S |
p. S149-S150 |
artikel |
852 |
Radiolabeled chimeric interlukine-1 (IL-1) receptor antagonist for imaging tumor microenvironment of colorectal cancer
|
Liu, Zhonglin |
|
|
76-77 |
S |
p. S202 |
artikel |
853 |
Radiolabeled gold nanoseeds containing substance P peptides: synthesis, characterization and evaluation in glioblastoma cells
|
Raposinho, Paula |
|
|
76-77 |
S |
p. S30 |
artikel |
854 |
Radiolabeled Microbubbles as a Theranostic Modality in Nuclear Medicine
|
Gower-Fry, Kaley |
|
|
76-77 |
S |
p. |
artikel |
855 |
Radiolabeled peptidomimetic inhibitors of the VEGF:NRP-1 complex as diagnostic: therapeutic radiopharmaceuticals
|
Masłowska, Katarzyna |
|
|
76-77 |
S |
p. S56 |
artikel |
856 |
Radiolabeled supramolecular coordination complexes targeted to somatostatin receptors
|
Deiser, Sandra |
|
|
76-77 |
S |
p. S73-S74 |
artikel |
857 |
Radiolabeling and biological evaluation of functionalized spherical nucleic acids
|
Auchynnikava, Tatsiana |
|
|
76-77 |
S |
p. S39-S40 |
artikel |
858 |
Radiolabeling and evaluation of cyclohexyl (5-(2-acetamidobenzo[d]thiazol-6-yl)-2-methylpyridin-3-yl) carbamate (PK68), a potent inhibitor for receptor interacting protein 1 kinase (RIPK1)
|
Kumata, Katsushi |
|
|
76-77 |
S |
p. S113 |
artikel |
859 |
Radiolabeling and evaluation of 68Ga-DOTA-F56 peptide targeting vascular endothelial growth factor receptor
|
Zhang, Qian |
|
|
76-77 |
S |
p. S222 |
artikel |
860 |
Radiolabeling and in vitro studies of scandium-44 with HOPO chelator for PET imaging
|
Gajecki, Leah |
|
|
76-77 |
S |
p. S52-S53 |
artikel |
861 |
Radiolabeling and preclinical evaluation of a novel PET ligand for imaging phosphodiesterase (PDE) 4B
|
Chen, Jiahui |
|
|
76-77 |
S |
p. S91-S92 |
artikel |
862 |
Radiolabeling of HER2 targeting single domain antibody with Tc-99m and Re-188
|
Altunay, Betül |
|
|
76-77 |
S |
p. S6 |
artikel |
863 |
Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice
|
Frindel, Mathieu |
|
2014 |
76-77 |
S |
p. e49-e57 nvt p. |
artikel |
864 |
Radiolabeling of hyaluronan and hyaluronan-α vβ6-Binding Peptide for PET imaging
|
Zhang, Hua |
|
|
76-77 |
S |
p. |
artikel |
865 |
Radiolabeling of small molecules and peptides with therapeutic radionuclide Cu-67 for theranostic applications
|
Pike, Susan |
|
|
76-77 |
S |
p. S156 |
artikel |
866 |
Radiolabeling of two different precursors of m-[211At] astatobenzylguanidine using 211At purified by wet extraction.
|
Kang, Choong Mo |
|
|
76-77 |
S |
p. |
artikel |
867 |
Radiolabelling of biomolecules with an original exo-maleimide prosthetic group
|
Richard, Mylène |
|
|
76-77 |
S |
p. S117-S118 |
artikel |
868 |
Radiolabelling of DOTA-Kisspeptin with gallium-68 and lutetium-177
|
Kleynhans, Janke |
|
|
76-77 |
S |
p. S143 |
artikel |
869 |
Radiolabelling of small extracellular vesicles with gallium-68
|
Kunnas, Jonne |
|
|
76-77 |
S |
p. |
artikel |
870 |
Radiometabolite structural confirmation of [11C]CS1P1, a promising radiotracer for imaging neuroinflammation of patients with Multiple Sclerosis
|
Qiu, Lin |
|
|
76-77 |
S |
p. |
artikel |
871 |
Radionuclide therapy with the second-generation Affibody molecule [188Re]Re-Z41071 improves survival in mice bearing human HER2-expressing xenografts
|
Liu, Yongsheng |
|
|
76-77 |
S |
p. S27 |
artikel |
872 |
Radiopharmaceutical preparation and quality control of 225Ac-DOTAGA-IAC for tumor targeted alpha therapy (TAT)
|
Pandey, Somit |
|
|
76-77 |
S |
p. S144-S145 |
artikel |
873 |
Radiopharmaceutical production and stability studies of 18F-rhPSMA-7.3 injection on a Siemens Explora GN Synthesis Module
|
Haka, Michael |
|
|
76-77 |
S |
p. |
artikel |
874 |
Radiopharmacological comparison of an Al18F- and 68Ga-labeled somatostatin agonist and antagonist in 2D and 3D models of BON-SSTR2 cells
|
Sihver, Wiebke |
|
|
76-77 |
S |
p. |
artikel |
875 |
Radiosynthesis and analysis of (S)-4-(3-[18F]fluoropropyl)-L-glutamic acid
|
Brown, Gavin |
|
|
76-77 |
S |
p. |
artikel |
876 |
Radiosynthesis and biological evaluation of a nicotinic acid hydroxamate derivative as a radioligand for HDAC6 PET imaging
|
Tago, Tetsuro |
|
|
76-77 |
S |
p. S107 |
artikel |
877 |
Radiosynthesis and biological evaluation of 10-[11C] methoxy-berberine as a novel PET tracer for visualizing berberine metabolism and distribution in mice
|
Zhang, Xiaojun |
|
|
76-77 |
S |
p. S69 |
artikel |
878 |
Radiosynthesis and biological evaluation of [18F]AG-120 as imaging agent for the detection of the mutant isocitrate dehydrogenase 1 in glioma by PET
|
Toussaint, Magali |
|
|
76-77 |
S |
p. |
artikel |
879 |
Radiosynthesis and biological evaluation of [18F]CooP: a brain-homing peptide for imaging glioblastomas using positron emission tomography
|
Dillemuth, Pyry |
|
|
76-77 |
S |
p. S18-S19 |
artikel |
880 |
Radiosynthesis and biological evaluation of [18F]R91150, a selective 5-HT2A receptor antagonist for PET imaging
|
Willmann, Michael |
|
|
76-77 |
S |
p. S35-S36 |
artikel |
881 |
Radiosynthesis and biological investigation of an 18F-labeled triazolopyridopyrazine-based inhibitor for imaging of the phosphodiesterase 2A enzyme (PDE2A) in brain
|
Wenzel, Barbara |
|
|
76-77 |
S |
p. S111 |
artikel |
882 |
Radiosynthesis and Characterisation of [18F]antagomir-223: A Potential PET Radiotracer for Imaging Neuroinflammation
|
Zientek, Simon |
|
|
76-77 |
S |
p. |
artikel |
883 |
Radiosynthesis and evaluation of a new PET tracer for imaging of leucine-rich repeat kinase 2
|
Mori, Wakana |
|
|
76-77 |
S |
p. |
artikel |
884 |
Radiosynthesis and Evaluation of a Novel 18F-Labeled Tracer for PET Imaging of Glycogen Synthase Kinase-3 (GSK-3)
|
Li, Yinlong |
|
|
76-77 |
S |
p. |
artikel |
885 |
Radiosynthesis and evaluation of [18F]SNFT-1 for imaging early tau deposition
|
Harada, Ryuichi |
|
|
76-77 |
S |
p. |
artikel |
886 |
Radiosynthesis and first preclinical evaluation of an 18F-radiolabelled ligand for cancer stem cells non-invasive PET imaging
|
Toussaint, Magali |
|
|
76-77 |
S |
p. S216 |
artikel |
887 |
Radiosynthesis and in vitro comparison of [225Ac]Ac-DOTA-dhPzPEG4- and [225Ac]Ac-macropa-tzPEG3Sq-conjugated ch806, a tumour-specific anti-EGFR antibody, and preclinical evaluation in a murine glioma model
|
Wichmann, Christian |
|
|
76-77 |
S |
p. S14-S15 |
artikel |
888 |
Radiosynthesis and in vitro evaluation of [99mTc]-labeled hyaluronic acid derivatives
|
Sarasamkan, Jiradanai |
|
|
76-77 |
S |
p. S156-S157 |
artikel |
889 |
Radiosynthesis and preclinical biodistribution of a carbon-11-labelled STING agonist
|
Hill, James |
|
|
76-77 |
S |
p. S193 |
artikel |
890 |
Radiosynthesis and preclinical evaluation of [11C]mitragynine isotopomers in rodents
|
Seo, Jinpyo |
|
|
76-77 |
S |
p. |
artikel |
891 |
Radiosynthesis and Preliminary Evaluation of a 18F-Labeled PET Tracer Targeting CYP1B1
|
Li, Yuying |
|
|
76-77 |
S |
p. |
artikel |
892 |
Radiosynthesis and preliminary evaluation of an 18F-labeled diarylpyrrole-based PET tracer targeting COX-2
|
Li, Yuying |
|
|
76-77 |
S |
p. |
artikel |
893 |
Radiosynthesis and preliminary evaluation of a novel PET probe for neuronal complement C3 activation imagingRadiosynthesis and preliminary evaluation of a novel PET probe for neuronal complement C3 activation imaging
|
Suzuki, Chie |
|
|
76-77 |
S |
p. |
artikel |
894 |
Radiosynthesis, in vitro and in vivo evaluation of [18F]Z-3540 for imaging 4R-tauopathies
|
Lindberg, Anton |
|
|
76-77 |
S |
p. |
artikel |
895 |
Radiosynthesis, in vitro and in vivo evaluations of [3H]/[18F]CBD-2115 as first in class radiotracers for imaging 4R-tauopathies
|
Lindberg, Anton |
|
|
76-77 |
S |
p. S9-S10 |
artikel |
896 |
Radiosynthesis of [11C]EHT1610, a potential radioligand for quantification of cerebral DYRK1A by PET imaging
|
POUTREL, Pauline |
|
|
76-77 |
S |
p. S95 |
artikel |
897 |
Radiosynthesis of 6-(2-cyclobutyl-5-(methyl-11C)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one and (2-cyclobutyl-3-(1H-indazol-5-yl)-5-[11C]methyl-3H-imidazo[4,5-b]pyridine for imaging γ-8 dependent transmembrane AMPA receptor regulatory protein
|
Yu, Qingzhen |
|
|
76-77 |
S |
p. S97-S98 |
artikel |
898 |
Radiosynthesis of D-[1-11C]alanine and D-[3-11C]alanine isotopomers
|
Rabbitt, Sarah |
|
|
76-77 |
S |
p. |
artikel |
899 |
Radiosynthesis of [18F]AmBF3-Tyr3-Octreotides with Tetrazine Ligation Based on the Inverse Electron-Demand Diels–Alder Reaction: Rapid, Catalyst-free and Mild Conversion of 1,4-Dihydropyridazines to Pyridazines
|
Otaru, Sofia |
|
|
76-77 |
S |
p. |
artikel |
900 |
Radiosynthesis of [18F]2- and [18F]4-fluoro[1,3]-pyrimidines
|
Kumar, Dileep |
|
|
76-77 |
S |
p. S82-S83 |
artikel |
901 |
Radiosynthesis of [18F]fluoroadenosine derivative : a new imaging agent for HSP70
|
Ghosh, Pradip |
|
|
76-77 |
S |
p. S72-S73 |
artikel |
902 |
Radiosynthesis of [18F]FP-CIT using azetidinium salt precursor and evaluation of radiochemical purity and stability
|
Kim, Dong Hyun |
|
|
76-77 |
S |
p. S126 |
artikel |
903 |
Radiosynthesis of 18F labelled D-amino acid tracers and their use for bacteria imaging
|
Sorlin, Alexandre |
|
|
76-77 |
S |
p. S68 |
artikel |
904 |
Radiosynthesis of [18F]talazoparib and biodistribution study in PC3 prostate tumor mice
|
Zhou, Dong |
|
|
76-77 |
S |
p. S45 |
artikel |
905 |
Radiosynthesis of [18F]VU6010572 as a PET radiotracer for imaging metabotropic glutamate receptor 3 (mGluR3)
|
Rong, Jian |
|
|
76-77 |
S |
p. S100-S101 |
artikel |
906 |
Radiosynthesis of new PET tracer targeting macrophage mannose receptor
|
Andriana, Putri |
|
|
76-77 |
S |
p. S62-S63 |
artikel |
907 |
Radiosynthesis of novel PET tracers for α-synuclein imaging
|
Hoang, Anh |
|
|
76-77 |
S |
p. S96 |
artikel |
908 |
Rapid and Efficient Syntheses of [11C]Trifluoroethoxy Heteroarenes with a Novel 11C-Labeling Synthon, [11C]CF3CH2OK
|
Zhao, Qunchao |
|
|
76-77 |
S |
p. |
artikel |
909 |
Rapid and precise quantification of radiochemical yields by analytical HPLC with post column injection
|
Humpert, Swen |
|
|
76-77 |
S |
p. |
artikel |
910 |
Rapid copper-mediated radiosynthesis optimization for a novel monoacylglycerol lipase PET tracer on a high-throughput microdroplet radiochemistry platform
|
Lu, Yingqing |
|
|
76-77 |
S |
p. |
artikel |
911 |
223Ra-radiolabeling: predicting stability using molecular modelling
|
Mohaman, Hamissou |
|
|
76-77 |
S |
p. S154-S155 |
artikel |
912 |
64 reactions in an hour using an automated, robotic high-throughput radiochemistry optimization platform
|
Jones, Jason |
|
|
76-77 |
S |
p. S59 |
artikel |
913 |
Real-time tracking of micro- and nanoplastics in mice after pulmonary exposure
|
Keinänen, Outi |
|
|
76-77 |
S |
p. |
artikel |
914 |
Recovery and purification of Zn-68 after cyclotron irradiation and Ga-68 recovery
|
Dunling, Eleanor |
|
|
76-77 |
S |
p. S43-S44 |
artikel |
915 |
Reducing protodeboronation using a novel boronic ester in the late-stage copper-mediated radiofluorination
|
Jaworski, Carolin |
|
|
76-77 |
S |
p. S46-S47 |
artikel |
916 |
Reducing the renal retention of 111In-labelled fibronectin-binding peptides through brush border-enzyme sensitive cleavable linkers
|
Valpreda, Giulia |
|
|
76-77 |
S |
p. S34-S35 |
artikel |
917 |
Reduction of pertechnetate by chemical and photochemical approaches and incorporation of Tc(IV) into titanium dioxide for wasteform development
|
Salcedo, Ramsey |
|
|
76-77 |
S |
p. S7 |
artikel |
918 |
Reductive N-11C-methylation of anilines in dimethyl sulfoxide using in situ generated [11C]formaldehyde and 2-methylpyridine-borane
|
Zhang, Ming-Rong |
|
|
76-77 |
S |
p. |
artikel |
919 |
Re/99mTc complexes of 1,8-naphthalimide with varying linkers as dual-modality imaging agents
|
Prabhu, Priyanka Jagadeesa |
|
|
76-77 |
S |
p. S41-S42 |
artikel |
920 |
Replacing high-performance liquid chromatography (HPLC) with high-resolution thin layer chromatography (TLC) for rapid radiopharmaceutical analysis
|
Holloway, Travis |
|
|
76-77 |
S |
p. S63 |
artikel |
921 |
Reports on the advancements of organotrifluoroborates and their use in PET imaging
|
Lozada, Jerome |
|
|
76-77 |
S |
p. |
artikel |
922 |
Rhenium and technetium complexes in extremely low oxidation states
|
Salsi, Federico |
|
|
76-77 |
S |
p. S3-S4 |
artikel |
923 |
Same-day solid target productions of clinically relevant quantities of 89Zr, 61Cu, and 68Ga by a single operator using a single chemistry module
|
Svedjehed, Johan |
|
|
76-77 |
S |
p. |
artikel |
924 |
Scale-up and optimisation of 199Au production from natPt0 and successful 199Au-labelling of bis-pyridine
|
Rosecker, Veronika |
|
|
76-77 |
S |
p. |
artikel |
925 |
Scale up production and purification of high specific activity lead-203 (203Pb)
|
Saini, Shefali |
|
|
76-77 |
S |
p. |
artikel |
926 |
Scandium-47 and lutetium-177 radiolabelling and stability studies of 1st and 2nd generation DOTA-triphenylphosphonium ligands – potential radionuclide theranostics for treatment of glioblastoma multi-forme
|
Wyatt, Naomi |
|
|
76-77 |
S |
p. S93-S94 |
artikel |
927 |
Scandium exopolysaccharide complexes: evaluation of antiproliferative properties of on several cancer cell lines
|
Munoz-Garcia, Javier |
|
|
76-77 |
S |
p. S195-S196 |
artikel |
928 |
Scandium(III) and macrocyclic cavity of DOTA-like ligands: implications for design of chelators for scandium radioisotopes
|
Urbanovsky, Peter |
|
|
76-77 |
S |
p. S68 |
artikel |
929 |
(S)-2-(3-(carboxymethyl)ureido)-3-((2-hydroxy-3,4-dioxocyclobut-1-en-1-yl)amino)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging
|
Liu, Tianqing |
|
|
76-77 |
S |
p. |
artikel |
930 |
SCIFI: exciting BODIPY compounds with 89Zr-generated Cerenkov radiation
|
Gristwood, Katie |
|
|
76-77 |
S |
p. S167 |
artikel |
931 |
Separation of cyclotron-produced cobalt-55/58 m from iron targets using cation exchange chromatography
|
Lin, Wilson |
|
|
76-77 |
S |
p. |
artikel |
932 |
Short PEG linkers considerably reduce background noise in immuno-PET tumor imaging
|
Nam, Bora |
|
|
76-77 |
S |
p. S207 |
artikel |
933 |
Silicon-based Fluoride Acceptor (SiFA) on solid supports: a new versatile tool for 18F-fluorination of peptides and biological structures
|
Steffann, Marine |
|
|
76-77 |
S |
p. S87 |
artikel |
934 |
Simple and quick indirect radioiodination to antibody without HPLC purification using fluorous solid-phase extraction and click reaction
|
Im, Changkeun |
|
|
76-77 |
S |
p. S125-S126 |
artikel |
935 |
Simple and rapid automated synthesis of L-[11C]glutamine
|
Fujinaga, Masayuki |
|
|
76-77 |
S |
p. S124-S125 |
artikel |
936 |
Simple method for the production of [11C]phosgene
|
Krzyczmonik, Anna |
|
|
76-77 |
S |
p. S72-S73 |
artikel |
937 |
Site-selective 18F-labelling of octreotide via disulfide rebridging
|
Richard, Mylène |
|
|
76-77 |
S |
p. S86 |
artikel |
938 |
Site-selective labelling of biomolecules via disulfide rebridging
|
Richard, Mylène |
|
|
76-77 |
S |
p. S4 |
artikel |
939 |
Site-specifically THP-functionalized hPD-L1 single-domain antibody: preliminary data toward kit development
|
Dierick, Herlinde |
|
|
76-77 |
S |
p. |
artikel |
940 |
Site-specific [68Ga]Ga radiolabelling of antibodies through methionine conjugation
|
Chi Yue, Thomas Tin |
|
|
76-77 |
S |
p. |
artikel |
941 |
Site-specific radiofluorination of peptides via chemoselective S-arylation with 4-[18F]Fluoroiodobenzene
|
Francis, Felix |
|
|
76-77 |
S |
p. S116 |
artikel |
942 |
Site-specific radiolabeling of an anti-HER2 single domain antibody fragment with an 211At-labeled prosthetic agent: preliminary evaluation of a potential targeted α-particle therapeutic
|
Feng, Yutian |
|
|
76-77 |
S |
p. S32 |
artikel |
943 |
Site-specific 89Zr-labeling of a VHH construct as a half-life extending building block for PET and TRNT applications
|
Leekens, Simon |
|
|
76-77 |
S |
p. |
artikel |
944 |
Small-molecule antagonist radiotracers for positron emission tomography imaging of the mu opioid receptor.
|
Plakas, Konstantinos |
|
|
76-77 |
S |
p. |
artikel |
945 |
Small molecule-based angiogenic radiotracer for early detection and progression management of pulmonary arterial hypertension
|
Yang, Zhen |
|
|
76-77 |
S |
p. S67 |
artikel |
946 |
Solid phase radiosynthesis of an 18F labeled olaparib derivative for PET imaging of PARP expression
|
Zhou, Dong |
|
|
76-77 |
S |
p. S222 |
artikel |
947 |
Solid polyamine adsorbents for [11C]CO2 capture, purification, and radiosynthesis
|
Chasse, Melissa |
|
|
76-77 |
S |
p. S23 |
artikel |
948 |
Sortase mediated conjugation and 89Zr-radiolabelling of the HER2 neu targeting G3-DARPin for in vivo PET imaging in BT-474-xenografts
|
Fay, Rachael |
|
|
76-77 |
S |
p. S89-S90 |
artikel |
949 |
SPAAC incorporation of fluorine into FC131 analogues towards discovery of CXCR4 radiopharmaceuticals
|
Mason, Julia |
|
|
76-77 |
S |
p. S202-S203 |
artikel |
950 |
Specific imaging of bacterial infections with 18F-labeled maltotriose ([18F]AAX90)
|
Landau, Felicitas |
|
|
76-77 |
S |
p. S8 |
artikel |
951 |
Stabilization of 68Ga-labeled [Thz14]Bombesin(7–14) analogue for imaging gastrin-releasing peptide receptor expression with positron emission tomography
|
Wang, Lei |
|
|
76-77 |
S |
p. |
artikel |
952 |
StarPEG Nanocarriers for Prostate Cancer Imaging and Drug Delivery
|
Meher, Niranjan |
|
|
76-77 |
S |
p. |
artikel |
953 |
StarPEG Nanocarriers for PSMA Targeted Radioligand Imaging and Therapy
|
Bidkar, Anil |
|
|
76-77 |
S |
p. |
artikel |
954 |
Structure-activity relationship of pyrazol-4-yl-pyridine derivatives for imaging the muscarinic acetylcholine receptor M4
|
Haider, Ahmed |
|
|
76-77 |
S |
p. S25 |
artikel |
955 |
Structure-activity relationship study of peptide Gastramide-01 (GA-01), a potent binder of cholecystokinin-2 (CCK-2) receptor and theranostic candidate
|
Rahimi, Marwa |
|
|
76-77 |
S |
p. S107 |
artikel |
956 |
Studies of [89Zr]ZrDFO*-Labeled Human Serum Albumin Applying Different Cysteine Bioconjugation Chemistry
|
Kronberger, Julia |
|
|
76-77 |
S |
p. |
artikel |
957 |
Studies on the novel scandium-47 labelled PSMA inhibitor targeting ligand
|
Wojdowska, Wioletta |
|
|
76-77 |
S |
p. S102 |
artikel |
958 |
Studying the effect of structural modification of porphyrin derivatives on tumor uptake: Is lipophilicity the sole criterion?
|
Guleria, Mohini |
|
|
76-77 |
S |
p. S45-S46 |
artikel |
959 |
Study of radiolabeled hepatotropic peptide derivatives for the diagnosis and treatment of hepatocellular carcinoma
|
Nahas, Hanadi |
|
|
76-77 |
S |
p. S41 |
artikel |
960 |
Study of radiolabeled nanoplastics: synthesis and in vitro stability evaluation of Cu-64 and Lu-177 labeled polypropylene (PP)
|
Kim, Heejung |
|
|
76-77 |
S |
p. |
artikel |
961 |
Subtype-selective vasopressin 1A receptor imaging by positron emission tomography
|
Haider, Ahmed |
|
|
76-77 |
S |
p. S58 |
artikel |
962 |
Supramolecular chemistry in the synthesis of radiopharmaceuticals
|
d’Orchymont, Faustine |
|
|
76-77 |
S |
p. S34 |
artikel |
963 |
Survey of the use of yttrium-90 in selective radiotherapy for primary liver cancer treatment
|
Tuan, Hoang |
|
|
76-77 |
S |
p. S48 |
artikel |
964 |
Syntheses and biological evaluation of two F-18 radiotracers for imaging MLKL in the brain
|
Huang, Tianyu |
|
|
76-77 |
S |
p. |
artikel |
965 |
Synthesis and Astatine Labeling of a bis-iminobiotin derivative with enhanced plasma stability
|
Washiyama, Kohshin |
|
|
76-77 |
S |
p. S121 |
artikel |
966 |
Synthesis and bioevaluation of a novel SPECT agent targeting breast cancer estrogen receptor
|
Lin, Xiaoru |
|
|
76-77 |
S |
p. S53 |
artikel |
967 |
Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity
|
Nag, Sangram |
|
|
76-77 |
S |
p. S26 |
artikel |
968 |
Synthesis and biological evaluation of 1-[2-(cyclopentadienyltr icarbonyltechnetium-99m)-N-vanillyferrocenecarboxamide for tumor imaging
|
Dallegi, Tesnim |
|
|
76-77 |
S |
p. S51 |
artikel |
969 |
Synthesis and characterization of new hydrophilic trithiol chelates and their radioarsenic complexes
|
Ma, Li |
|
|
76-77 |
S |
p. S30 |
artikel |
970 |
Synthesis and characterization of novel enrofloxacin derivatives and their rhenium and technetium-99m tricarbonyl complexes as potential therapeutic or diagnostic agents
|
Tzovas, Georgios |
|
|
76-77 |
S |
p. S99 |
artikel |
971 |
Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Radioligand Therapy Applications
|
Muzzioli, Riccardo |
|
|
76-77 |
S |
p. |
artikel |
972 |
Synthesis and evaluation of a bivalent radiohapten for DOTA-based pretargeted radioimmunotherapy
|
Veach, Darren |
|
|
76-77 |
S |
p. S61-S62 |
artikel |
973 |
Synthesis and evaluation of a fluorinated PET imaging probe targeting fibroblast activation protein (FAP)
|
Filippi, Nicolò |
|
|
76-77 |
S |
p. |
artikel |
974 |
Synthesis and evaluation of a [68Ga]Ga-labeled water soluble porphyrin as a tumor targeting theranostic agent: in-vitro and in-vivo studies
|
Kumar, Naveen |
|
|
76-77 |
S |
p. S183-S184 |
artikel |
975 |
Synthesis and evaluation of a 68Ga-labeled PSMA-targeting tracer with a rigid linker to reduce kidney and salivary gland uptake
|
Kuo, Hsiou-Ting |
|
|
76-77 |
S |
p. |
artikel |
976 |
Synthesis and evaluation of an 18F labeled conformationally flexible benzamide analog ([18F]Fluoroethyl HY-2-92) for D3R PET Studies
|
Kim, Ho Young |
|
|
76-77 |
S |
p. S96-S97 |
artikel |
977 |
Synthesis and evaluation of an 18F-labeled PSMA-targeting tracer for imaging prostate cancer with positron emission tomography
|
Lu, Kelly |
|
|
76-77 |
S |
p. |
artikel |
978 |
Synthesis and evaluation of a novel PET tracer for imaging monoamine oxidase-B
|
Fujinaga, Masayuki |
|
|
76-77 |
S |
p. |
artikel |
979 |
Synthesis and evaluation of a radioligand for PET imaging of hepsin
|
Park, Ji-Hun |
|
|
76-77 |
S |
p. S183 |
artikel |
980 |
Synthesis and evaluation of 18F-labeled tracer candidates targeting the Abelson non-receptor tyrosine kinase in Parkinson’s disease
|
Stéen, E. Johanna |
|
|
76-77 |
S |
p. S27 |
artikel |
981 |
Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for amyloid PET-imaging
|
Schlein, Eva |
|
|
76-77 |
S |
p. S101-S102 |
artikel |
982 |
Synthesis and evaluation of 68Ga-labeled [Leu13ψThz14] Bombesin(7-14) analogues for imaging gastrin-releasing peptide receptor expression with positron emission tomography
|
Wang, Lei |
|
|
76-77 |
S |
p. S219 |
artikel |
983 |
Synthesis and Evaluation of Modified NOTA Chelators Labeled with [99mTc]Tc/Re-Tricarbonyl for Potential Theranostic Agent Development
|
Kamboj, Ritin |
|
|
76-77 |
S |
p. |
artikel |
984 |
Synthesis and evaluation of novel 18F-labeled indole-based derivatives as sigma-2 receptor radioligands for imaging the proliferative status of tumors
|
Zhang, Ying |
|
|
76-77 |
S |
p. S197 |
artikel |
985 |
Synthesis and evaluation of novel PET ligands for imaging Orexin2 receptor (OX2R)
|
Rong, Jian |
|
|
76-77 |
S |
p. S101 |
artikel |
986 |
Synthesis and evaluation of PET ligands for monoacylglycerol lipase in brain
|
Mori, Wakana |
|
|
76-77 |
S |
p. S99 |
artikel |
987 |
Synthesis and evaluation of [186Re]Re(CO)3-p-NCS-benzyl-NODAGA-Ser2-RM2 for future development as a GRPR-antagonist for targeting prostate cancer
|
Hoerres, Rebecca |
|
|
76-77 |
S |
p. S90-S91 |
artikel |
988 |
Synthesis and in vitro and in vivo evaluation of a new 64Cu-semicarbazone complex: potential theranostic radiopharmaceutical for hypoxic tumor
|
Aljammaz, Ibrahim |
|
|
76-77 |
S |
p. S52 |
artikel |
989 |
Synthesis and in vitro stability evaluation of Cu-64 labeled branched polyethyleneimine (BPEI)
|
Choi, Se-hwan |
|
|
76-77 |
S |
p. |
artikel |
990 |
Synthesis and in vitro stability evaluation of Cu-64 labeled linear polyethylenimine (LPEI) as a preliminary study
|
Jang, Jaebaek |
|
|
76-77 |
S |
p. |
artikel |
991 |
Synthesis and in vivo characterization of a heterobivalent radiotracer targeting PSMA and GRPR for prostate cancer imaging
|
Bailly, Thibaud |
|
|
76-77 |
S |
p. S177-S178 |
artikel |
992 |
Synthesis and optimization of radiotracers targeting P2Y12 receptors for positron emission tomography imaging of neuroinflammation
|
Pincemail, Eugénie |
|
|
76-77 |
S |
p. S99-S100 |
artikel |
993 |
Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor
|
Högnäsbacka, Antonia |
|
|
76-77 |
S |
p. S38-S39 |
artikel |
994 |
Synthesis and preclinical evaluation of [18F]DASA-10 a second generation PKM2 specific radiotracer
|
Beinat, Corinne |
|
|
76-77 |
S |
p. |
artikel |
995 |
Synthesis and preclinical evaluation of [methylpiperazine-11C]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors
|
Högnäsbacka, Antonia |
|
|
76-77 |
S |
p. S51-S52 |
artikel |
996 |
Synthesis and preclinical evaluation of 99mTc sandwich complexes targeting LAT1 and CRBN
|
Sadeghi, Saman |
|
|
76-77 |
S |
p. S32 |
artikel |
997 |
Synthesis and preclinical evaluation of PD-L1 PET tracer [18F]FDHPA in mice
|
Tong, Jie |
|
|
76-77 |
S |
p. S214 |
artikel |
998 |
Synthesis and Preclinical Evaluation of Three Novel 68Ga-labeled PSMA-FAP Heterodimeric Tracers for Imaging of Prostate Cancer
|
Wang, Lei |
|
|
76-77 |
S |
p. |
artikel |
999 |
Synthesis and preliminary evaluation of novel aminoimidazoline derivatives targeting the norepinephrine transporter
|
Lu, Jie |
|
|
76-77 |
S |
p. S199 |
artikel |
1000 |
Synthesis and preliminary in-vitro studies of [99mTc][TcN(PNP)]-biphosphonates as new bone-radiopharmaceuticals.
|
Carpanese, Debora |
|
|
76-77 |
S |
p. S44-S45 |
artikel |